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blind! and! develop! deafness! during! life,! some! patients! also! have! cognitive! impairments.! The!
causative! gene! (NDP)! is! very! small! but! crucial! for! proper! vascularization! during! embryonic!
development!and!adult!homeostasis.!Norrin!is!an!unconventional!Wnt!ligand,!which!only!binds!
one!single!Wnt!receptor,!but!in!addition,!Norrin!can!directly!inhibit!another!important!signaling!
pathway,! the!TGFXβ!pathway.!This!WntXreceptor! selectivity!on! the!one!hand!and! the!pathway!
plurality! on! the! other! hand! are! of! special! interest.! Recombinant! human!Norrin! could! help! to!
elucidate! structural! properties! of!Norrin’s! interaction!with!other!proteins! and! also! to!develop!




My!second! interest! is! the! identification!of!new!genes! involved! in! retinal!diseases,! to!elucidate!
their! function,! and! pathophysiological! mechanisms! leading! to! the! disease.! We! screened! 10!
genes! in!more! then!200!patients!and! identified!79!potentially!disease! relevant!DNA!sequence!




that! the!mutant!ATOH7! is!degraded!faster!compared!to!the!wild! type!ATOH7.! In!another!case!
(ZNF408)!we! could! identify! a! new!gene! involved! in! retinal! vascularization! for! the! first! time! in!
collaboration!with!Prof.!Frans!Cremers!from!the!Department!of!Human!Genetics!at!the!Radboud!
University! in!Nijmegen!(Holland).!Other!candidate!gene!projects!are!still!ongoing,!but!revealed!
interesting! results! already.! This! will! help! to! better! understand! molecular! mechanisms! in! the!







Entwicklungsstörung.! Patienten! werden! häufig! blind! geboren! und! entwickeln! eine! Taubheit,!
manche! Patienten! haben! auch! kognitive! Einschränkungen.! Das! krankheitsverursachende! Gen!
(NDP)! ist! sehr! klein,! aber! äusserst!wichtig! für! die! korrekte! Entwicklung! des! Blutgefässsystems!
während! der! embryonalen! Entwicklung! und! der! adulten! Homeostase.! Norrin! ist! ein!
ungewöhnlicher!Wnt!Ligand,!welcher!nur!einen!einzelnen!Wnt!Rezeptor!bindet.!Zusätzlich!aber!
kann! Norrin! einen! anderen! Signalweg,! den! TGFXβ! Signalweg,! direkt! inhibieren.! Diese! Wnt!
Rezeptor! Selektivität! einerseits! und! die! Signalweg! Pluralität! andererseits! sind! von! speziellem!
Interesse.! Rekombinantes! humanes! Norrin! könnte! helfen! die! strukturellen! Eigenschaften! von!
Norrin’s! Interaktionen! mit! anderen! Proteinen! aufzuklären! und! pharmakologische! Wirkstoffe,!
welche! diese! Signalwege! beeinflussen,! zu! entwickeln.! Deshalb! bin! ich! besonders! daran!
interessiert,! ein! System! zur! Produktion! und! Aufreinigung! von! unlimitierten! Mengen! an!




Netzhaut! verursachen,! der! Aufklärung! von! deren! Funktion! und! der! pathophysiologischen!
Mechanismen,! welche! zur! Krankheit! führen.! Wir! untersuchten! 10! Gene! in! mehr! als! 200!
Patienten! und! identifizierten! 79! potentiell! krankheitsrelevante! DNA! Sequenzevariationen! in!
Patienten!mit!verschiedenen!Fehlentwicklungen!der!Netzhaut.! In!einem!Gen!(ATOH7)!konnten!
wir! den! krankheitsverursachenden!molekularen!Mechanismus! identifizieren.! Die! Deletion! des!
grössten!Teils!der!DNA!bindenden!Domaine!von!ATOH7!führt!zu!einer!Unterrepresentation!des!
Proteins! im! Zellkern.! Des! Weiteren! konnten! wir! zeigen,! dass! ATOH7! vom! cytoplasmatischen!
Proteasom! abgebaut! wird! und! dass! das! mutante! ATOH7! schneller! abbgebaut! wird! als! das!
normale! Protein.! In! einem! anderen! Fall! (ZNF408)! konnten! wir,! in! Zusammenarbeit! mit! Prof.!
Frans! Cremers! vom!Department! of! Human! Genetics! an! der! Radboud! Universität! in! Nijmegen!
(Holland),!ein!neues!Gen!identifizieren,!welches!in!der!retinalen!Blutgefässbildung!involviert!ist.!
Andere! Kandiadatengenprojekte! sind! noch! laufend,! haben! aber! bereits! interessante!Resultate!
gezeigt.! Diese! werden! helfen! die! molekularen! Mechanismen! in! Netzhautfehlentwicklungen!



















































































The! capsule! of! the! eye! consists! of! three! layers! (Figure! 1).! The! first! and! outermost! layer,! the!
tunica!oculi!externa,!is!stick!and!tough!and!consists!of!connective!tissue,!which!gives!the!eye!its!
integrity!as!a!globe!and!protects!its!structures!inside.!The!front!part!of!the!connective!tissue!is!
specialized! in! terms!of! collagen! fiber!orientation!and! called! cornea.! The! collagen! fibers! in! the!






adjusting! to! different! levels! of! light,! so! that! under! different! light! conditions! always! the!
appropriate!amount!of! light!can!enter!the!eye.!The!second!part!of!the!uvea!is!the!ciliary!body,!
which! produces! aqueous! humor! and! contains! ciliary! muscles.! The! aqueous! humor! is! a! clear!
gelatinous!fluid,!secreted!into!the!posterior!and!anterior!chamber!between!lens!and!cornea.! It!
also!nourishes! the! lens.!The!ciliary!muscles!can!alter! the!shape!of! the! lens!by!contraction!and!
thus!light!gets!focused!onto!the!retina.!This!process!is!called!accommodation.!The!third!part!of!
the! uvea! is! the! choroid,! which! is! located! at! the! back! of! the! eye.! It! is! a! vascular! tissue,! that!
provides!oxygen!and!nutrients!to!the!photoreceptors!at!the!outer!part!of!the!retina.!
The!retina! is! the! third! layer!of! the!eye!capsule,!which! is!called! tunica!oculi! interna.!The!retina!
consists!of!neural!and!glial!cells!and!contains!blood!vessels.!It!is!the!most!important!and!complex!
structure!in!the!eye!and!will!be!described!in!more!detail!later.!
The! eyeball! (Bulbus! oculi)! is! anatomically! subdivided! into! two! parts,! the! anterior! and! the!
posterior! segment.! The! anterior! segment! includes! the! lens! and! everything! distal! to! the! lens.!
Everything!proximal!belongs!to!the!posterior!segment.!To!finish!the!gross!anatomy!of!the!eye!I!
would! like! to! introduce! one! additional! structure! of! the! posterior! segment,! the! vitreous,! a!













of! the! central! nervous! system! (CNS).! The! vertebrate! retina! develops! in! a! highly! conserved!
manner,! from! the! uniform! neuroepithelium! towards! a! complex! laminar! structure! with! seven!
major! cell! types,! six! neuronal! and! one! glial! (Holt! et! al.! 1988,! Turner! et! al.! 1987,!Wetts! et! al.!
1988).!The!firstXborn!neurons! in!the!retina!are!the!retinal!ganglion!cells!(RGC).!Then!amacrine,!
horizontal,! and! cone! photoreceptor! cells! develop! in! an! overlapping! phase,! followed! by! rod!





Adjacent!to!the!vitreous,! the! inner! limiting!membrane!(ILM)! is! the!first! layer!of! the!retina!and!
functions! as! a! physical! boundary! between! vitreous! and! retina.! The! second! layer! is! the! nerve!
fiber! layer! (NFL),!which! is! formed!by!RGC!axons.!The!ganglion! cell! layer! (GCL)! consists!of!RGC!
nuclei.!RGCs!are!the!firstXborn!neurons!in!the!retina!of!all!vertebrates.!Their!axons!assemble!the!
optic! nerve,! and! convey! light! signals! from! the! retina! to! the! lateral! geniculate! nucleus! from!
where! visual! information! is! processed! to! the! visual! cortex.! In! addition! a! subset! of! RGC! axons!
projects!directly! to! the!suprachiasmatic!nucleus,!which!controls!circadian! rhythm.! In! the! inner!
plexiform! layer! (IPL)! bipolar! cells! are! connected! to! the! RGCs.! The! inner! nuclear! layer! (INL)! is!
formed!by!bipolar!cell!nuclei.! In!the!outer!plexiform!layer!(OPL)!photoreceptors!are!connected!
to! the! bipolar! cells.! In! the! transmission! between! photoreceptors! and! bipolar! cells! the! visual!
 17 
information! gets! processed! on! a! synaptic! level.! These! synapses! are! laterally! connected! by!





color! vision.! Interestingly,! the! photosensitive! cells! are! located! at! the! outer! edge! of! the!
vertebrate! retina,! so! that! the! light! has! to! pass! through! all! neurons!of! the! retina! to! reach! the!
photosensitive!cells,!therefore!it!is!also!called!inverted!retina.!The!photoreceptors!are!in!contact!
with! the! light!absorbing! retinal!pigment!epithelium! (RPE),!which! is! the! last! layer!of! the! retina!
and!restores!the!photopigment!retinal.!Retinal! is!a!carotinoid!and!can!absorb! light! in! its!11Xcis!
conformation!and!therefore!is!the!key!molecule!to!convert!electromagnetic!radiation!(light)!into!









has! also! been! shown! that! Müller! glia! cells! can! dedifferentiate! after! retinal! injury! and!
differentiate!into!multiple!retinal!cell!types!(Ooto!et!al.!2004,!Osakada!et!al.!2007).!The!second!




and! function! as! a! scaffold! for! the! subsequent! invasion! of! blood! vessels.! The! may! also! have!
metabolic!function!in!the!retina.!Microglia!are!the!third!glial!cell!type!present!in!the!retina!and!
are! the! macrophages! of! the! CNS.! Retinal! microglia! comprise! a! heterogeneous! population! of!
cells.!Some!have!a!mesodermal!origin!and!invade!the!retina!during!early!gestation!(Diazaraya!et!
al.!1995,!Ling!et!al.!1993,!Streit!2001).!Others!might!be!of!myeloid!origin!and!enter! the!retina!









the! requirements! of! the! high! metabolic! rate! of! the! retina,! several! blood! vessel! systems! are!
present! in! the! eye.! During! development! the! immature! mammalian! eye! is! nourished! by! the!
transient! hyaloid! vasculature,! including! the! pupillary!mambrane! (PM),! tunica! vasculosa! lentis!
(TVL),!as!well!as!the!vasa!hyaloidea!propria!(VHP)!and!the!hyaloid!artery!(HA).!The!HA!enters!the!
eye! at! the! optic! disc! and! extends! through! the! vitreous! towards! the! lens.! The! VHP! are! small!









a! highly! stereotypic! manner.! Blood! vessels! enter! the! eye! through! the! optic! nerve! head! and!
spread!radially!along!a!preXestablished!astrocytic!network!in!the!NFL!towards!the!periphery.!In!
humans! the! retinal! vasculature! of! the! primary! superficial! vascular! plexus! (SVP)! reaches! the!
periphery!just!before!birth,!in!mice!about!eight!days!postnatally!(Figure!3).!
When! the! primary! SVP! is! established,! blood! vessels! start! to! remodel! into! a!mature! SVP! and!
sprout! from!the!NFL! into!deeper! regions!of! the!retina!along!the!processes!of!Müller!glia!cells.!
First,!the!deeper!vascular!plexus!(DVP)!is!formed!at!the!boundary!between!OPL!and!INL,!a!third!
retinal!blood!vessel! layer,! the! intermediate!vascular! layer! (IVL)!at!the!border!between!INL!and!
IPL,!is!established!last.!!
The! retinal! vasculature! is! similar! to! the! cerebral! vasculature! in! respect! to! its! barrier! function,!
















The! retinal! vasculature! undergoes! drastic! changes! during! development.! Vessel! regression,!
vascular! remodeling,! sprouting! angiogenesis,! vessel! differentiation! and!maturation! are! crucial!
during! this! process! and! depend! on! different! cell! types! and! proper! signaling! pathways! among!
these! cells.! The! understanding! of! normal! and! diseaseXspecific! vascular! development! and!
remodeling! have! been! constantly! expanded! during! the! last! decades,! and! are! the! key! to!
understand! retinal! vascular! diseases,! including! diabetic! retinopathy! (DR),! retinopathy! of!






complex! architecture! lead! to! retinal! dysfunction! and! are! the!major! cause! of! blindness! in! the!
western! world.! The! absence! of! only! one! of! these! three! retinal! blood! vessel! layers! leads! to!
hypoxia! and! results! in! neuronal! degeneration.! On! the! other! hand,! excessive! and! abnormal!
growth! of! new! blood! vessels,! called! neovascularization,! can! disturb! proper! visual! function! as!
well.!Overall,!the!development!of!the!retinal!vasculature!is!highly!tuned!and!any!misXregulation!
of!this!process!may!lead!to!visual!impairment.!Over!the!last!years,!enormous!progress!has!been!
achieved! in! the!understanding!of! the!molecular!basis!of! retinal! vascularization!and!associated!
pathophysiological!mechanisms.!This!might!lead!to!the!development!of!new!treatments!leading!




DR! (MIM#! 603933)! is! the! leading! cause! of! vision! loss! in! workingXage! adults.! As! the! term!
suggests,!it!is!a!microvascular!complication!in!the!retina!of!patients!with!diabetes!(Antonetti!et!
al.! 2012).! It! is! characterized! by! the! loss! of! pericytes,! formation! of!microaneurysms! as!well! as!
hyperpermeability!of! the! retinal! vasculature!and! therefore!often! leads! to!macular!edema!and!




which! causes! traction! of! the! retina.! It! is! thought! that! genetic! predispositions! influence! the!
development!of!DR.!
1.4.2!Retinopathy!of!prematurity!(ROP)!
ROP! (MIM#!133780),! previously! known!as! retrolental! fibroplasia,! effects!preterm!babies,!who!
are!born!before!completion!of!the!31st!week!of!gestation!with!low!birth!weight!(≤1250g,!mean:!
700g)!(Gilbert!2008,!Terry!1946).!ROP!is!the!major!cause!of!childhood!blindness!in!the!western!
world! and! is! increasingly! prevalent! in! the! developing! world.! The! retinal! vasculature! of! these!
babies!is!not!fully!developed!when!they!are!born.!In!normal!development,!hypoxia!in!the!inner!
retina! present! at! this! stage! triggers! the! formation! of! the! retinal! blood! vessel! system.! These!





manifestations!and! is! categorized! into! five! stages.! Stage! I! is! the!mildest! form!with!only!minor!








material! in! the!macular! region! seen! as! yellow! spots,! also! called! drusen.! The!wet! form! is! less!





retina.! Laser! photocoagulation! and! antiXVEGF! therapies! are! the! most! commonly! used!
treatments! at! the!moment! for! all! of! these! diseases.! There! is! another! group! of! eye! diseases,!
called! exudative! vitreoretinopaties! (EVRs),! from! which! we! might! learn! how! pathological!




Exudative! vitreoretinopaties! (EVRs)! is! a! group! of! eye! disorders! characterized! by! incomplete!
retinal!vascularization!and!the!formation!of!fibrovascular!masses!in!the!eye!(Figure!4A,!B,!C).!The!
symptoms!range!from!mild!forms!with!completely!asymptomatic!patients!to!very!severe!forms!
with!bilateral! congenital! retinal!nonXattachment! that! causes!blindness! (Berger!et! al.! 2010).! Its!
clinical!appearance!shows!highly!variable!phenotypes,!even!within!a!family!or!between!the!two!
eyes!of!an!affected!patient.!In!mild!cases,!an!avascular!periphery!of!the!retina!can!only!be!seen!




To! date,! mutations! in! four! genes! have! been! associated! with! the! pathogenesis! of! EVR,! all!
involved!in!the!same!signaling!pathway,!the!so!called!Norrin/Wnt!signaling!pathway.!Norrin/Wnt!
signaling! has! been! shown! to! be! important! for! proper! eye! development! and! retinal!
vascularization!(Xu!et!al.!2004,!Ye!et!al.!2009).!









(Junge! et! al.! 2009).! TSPAN12! might! be! important! to! assemble! the! receptors! in! the! cell!
membrane! to!ensure!proper!Norrin/Wnt! signaling.!Mutations! in! all! of! these! four! genes! (NDP,0
FZD4,0LRP5!and!TSPAN12)!lead!to!similar!ocular!phenotypes!(Berger!et!al.!1992b,!Nikopoulos!et!
al.! 2010,! Poulter! et! al.! 2010,! Robitaille! et! al.! 2002,! Toomes! et! al.! 2004).! EVR! is! a! genetically!
heterogeneous! group! of! diseases!with! different! patterns! of! inheritance! (autosomal! dominant!
(adFEVR;!MIM#!133780),! autosomal! recessive! (arFEVR;!MIM#!601813),! and! XXlinked! recessive!
(FEVRX;!MIM#! 305390! and! ND;!MIM#! 310600).! The!most! prevalent! pattern! of! inheritance! in!
FEVR!is!autosomal!dominant,!which!can!be!caused!by!mutations!in!either!of!two!genes!FZD4!and!





XXlinked! recessive! neurodevelopmental! disorder.! The! NDP! gene! is! the! only! gene! in! which!







1961,!Warburg!1963,!Warburg!1966).!The!ocular!phenotype,!which! is! characterized!by! fibrous!
and! vascular! changes,! is! usually! bilateral! and! symmetric,! present! at! birth! and! progressive.! At!
birth!the!eyes!might!appear!normal!but!usually!the!first!sign!in!ND!gets!evident!in!infancy,!which!
is! leukocoria! (Figure! 4C).! Leukocoria! is! a! reflection! of! light! by! retrolental! fibrotic! masses!
(pseodoglioma)!(Figure!4E)!appearing!as!a!yellowishXwhite!dot!in!the!pupil!of!an!infant.!Clinical!
manifestations!in!the!eye!include!opacification!of!the!lens!(cataract),!posterior!synechiae!(iris!to!
lens),! anterior! synechiae! (iris! to! cornea),! iris! atrophy,! shallowing! of! anterior! chamber! with!
occlusion! of! the! outflow! tracts! which! may! result! in! increased! intraocular! pressure! and! pain,!
corneal!opacification,!band!keratopathy,!reduction!of!intraocular!pressure,!and!shrinking!of!the!
globe!(phthisis!bulbi)! (Figure!4F).!Overall,! the!phenotype!can!vary!even!within!a!family!(Berger!
and!Ropers!2001,!Allen!et! al! 2006,! Zaremba!et! al.! 1998).! The!ocular!phenotype!of!ND! can!be!
similar!to!EVR,!PFVS,!ROP!and!Coats’!disease.!Beside!the!ocular!phenotype,!most!of!the!affected!
patients!suffer!from!a!progressive!hearing!loss!(Halpin!et!al.!2005,!Halpin!and!Sims!2008,!Smith!
et! al.! 2012).! In! the! literature,! it! is! often!written! that! about! 30%! suffer! from!hearing! loss,! but!
recent!data!suggest!an!almost!complete!penetrance!of!hearing!loss!in!ND!patients!(Smith!et!al.!
2012).! Further,! systemic!neurological! signs!were!described! in!approximately!30%! X!50%!of!ND!
patients,! including!developmental!delay/mental!retardation,!psychoticXlike!features,!behavioral!
abnormalities,! seizures,! and! autism! spectrum! disorders.! Several! patients! with! very! complex!










Figure! 4:!Characteristic! clinical!manifestation! of! the! ocular! ND! phenotype.! (A)! Fluorescein! angiogram!































with! retinal! vessel! leakage,! subretinal! exudation,! and! retinal! detachment! (Coats! 1908).! It! is!
suggested! that! CD! might! be! secondary! to! somatic! NDP! gene! mutations! (Black! et! al.! 1999).!
Overall,! CD! etiology! is! unknown! and! lots! of! different! reports! describe! additional! syndromic!
manifestations!including!neurological!symptoms!(reviewed!by!Muletarow!et!al.!2004).!
1.6#The#Norrie#disease#pseudoglioma#(NDP)#gene#
The! Norrie! disease! pseudoglioma! (NDP)! gene! (NM_000266)! has! been! genetically! linked!
(BleekerXWagemakers!et!al.!1985), physically!mapped!(Sims!et!al.!1992)!and!positional!cloned!on!
the!proximal! short! arm!of! the!X! chromosome! (Xp11.4Xp11.3)! (Berger!et! al.! 1992a,!Chen!et! al.!
1992).!The!human!gene!spans!24729!bp!of!genomic!DNA!and!consists!of! three!exons!and!two!

















INL,! and!GCL!of! the! retina! in! three!different! species! (mice,! rabbit,! and!human)! (Hartzer! et! al.!
1999).! Further! high! expression! levels! were! detected! in! the! cerebellar! granular! layer,!
hippocampus,!olfactory!bulb,!cortex,!and!epithelium!of!the!rabbit!brain.!Ye!et!al.!reported!that!
Norrin! is! expressed! in!Müller! glia! cells! in! all! ages! postnatally! using! a! knockXin! mouse,! which!
carries! the! coding! sequence! of! human! placental! alkaline! phosphatase! (AP)! at! the!NDP! locus!
(NdpAP)!(Ye!et!al.!2009).!The!same!group!published!recently!a!comprehensive!report!about!the!
expression!of!the!NdpAP!allele!(Ye!et!al.!2011).!They!found!Norrin!to!be!expressed!at!E!10.5!at!the!
optic! stalk! of! the! developing! retina,! and! between! E! 15.5! and! PND! 0! Norrin! expression! is!
apparent!at!the!optic!disc.!From!PND!0!to!PND!3!NdpAP0expression!is!detectable!across!the!whole!
retina!without! a! spatial! gradient.! At! E! 10.5! Norrin! is! also! expressed! in! dorsal! and!midXdorsal!
regions!of!the!neural!tube!and!the!hindbrain.!At!E!15.5!Norrin!expression!can!be!seen!in!several!
brain!regions:!the!olfactory!bulb!and!along!the!lateral!olfactory!tract,!the!amygdala,!the!inferior!
region! of! the! subventricular! zone! (SVZ)! of! the! lateral! ventricles,! the! territories! flanking! the!
medial! ganglionic! eminence,! the! hypothalamus,! within! the! posterior! thalamus,! and! the!
cerebellar! primordium.! In! adult! brain! tissue! Norrin! expression! can! be! seen! extensively! in!
astrocytes!of!the!forebrain!and!the!whole!diencephalon,!and!in!Bergman!glia!of!the!cerebellum.!
At!PND!2!Norrin!expression!was!found!in!the!inner!ear!in!highly!vascularized!tissue!including!the!
lateral! wall! adjacent! to! the! stria! vascularis! and! between! the! organ! of! Corti! and! the! spiral!
ganglion.!This!expression!pattern!in!the!inner!ear!is!maintained!in!adult!stages.!Further,!Norrin!
mRNA!expression!was!detected!by!RTXPCR!in!different!mouse!tissues,!including!kidney,!lung,!and!
ovary! (Luhmann!et!al.! 2005b).!High!expression!was!detected! in!brain,! epididymus!and!uterus,!











Figure! 6:!Multiple! protein! sequence! alignment! of! Norrin.! Norrin! is! a! highly! conserved! protein.! Colors!





Sequence! pattern! searches! and! three! dimensional! modeling! of! Norrin! suggested! a! tertiary!
structure!that!is!similar!to!the!transforming!growth!factor!β!(TGFXβ)!(Meitinger!et!al.!1993).!TGFX
β! belongs! also! to! the! cystineXknot! growth! factor! superfamily! as! well! as! nerve! growth! factor!




knot! growth! factor! superfamily! do! not! show! significant! sequence! homology! they! share! a!




















position! 95),! which! is! important! for! dimerization! of! TGFXβ,! suggests! a! similar! dimerization!
mechanism!of! these! two!proteins! (Meitinger! et! al.! 1993).!However,! there!are! conflicting!data!
regarding! the! functional! role! of! the! cysteine! at! position! 95! in! Norrin.! One! report! used! a!
p.Cys95Ala! mutant! and! showed! that! oligomerization! is! disrupted! but! dimerization! occurred!
(PerezXVilar! and! Hill! 1997).! Another! report,! using! a! p.Cys95Arg! substitution,! predominantly!
detected!this!mutant!Norrin!in!a!monomieric!form!(Junge!et!al.!2009).!But!also!small!fractions!of!
dimers! were! detected! and! the! authors! suggest! that! these! dimers! might! have! formed! by!
alternative!disulfide!bonding.!Interestingly,!the!p.Cys95Arg!mutant!could!bind!FZD4!but!was!not!






Norrin! plays! an! important! role! in! the! development! of! the! retinal! vasculature! and! the!








Norrin! and! its! high! affinity! receptor! FZD4! and! coXreceptor! LRP5! are! crucial! for! retinal!
vascularization.! Upon! binding! of! this! complex! βXcatenin! is! stabilized! in! the! cell! and! LEF/TCFX
mediated!transcription!is!activated!(Xu!et!al.!2004).!FZD4!is!the!only!Norrin!receptor!among!the!





(Ye! et! al.! 2009).! Extensive! mutational! analysis! of! NorrinXFZD4! recognition! was! conducted!
(Smallwood!et! al.! 2007),! but! so! far!no! crystal! structure!of! this! complex! is! available.!However,!






enter! the! retina! (Richter! et! al.! 1998).! The! persistence! of! the! hyaloid! vessel! system!might! be!
secondary!due! to!hypoxic! condition! in! the! retina,! and! remains! intact! to!nourish! the!avascular!
retina!with!oxygen,!or!it!is!a!primary!effect!of!Norrin.!Wnt7b/Fzd4!signaling!has!been!shown!to!
be!involved!in!the!microglia!dependent!regression!of!the!hyaloid!vessels!and!Norrin!might!have!
a! similar! function! (Lobov! et! al.! 2005).! Also!Fzd4X/X,! Lrp5X/X,! and!Tspan12X/X!mice! have! a! delayed!




vessels! in! the!Ndpy/X!mice!are! fenestrated! (Richter!et!al.!1998).!This! fenestration!and! leakiness!
might!be!due!to!the!upregulation!of!Plvap!(plasmalemma!vesicle!associated!protein),!also!called!
MECAX32,! in! the! Ndpy/X! model! (Schaefer! et! al.! 2009).! PLVAP! is! a! membrane! glycoprotein!
important! for! blood! vessel! fenestration! which! is! normally! not! expressed! in! the! retinal!
vasculature!to!maintain!the!BRB!(Hallmann!et!al.!1995).!Further,!Plvap!is!strongly!upregulated!in!
a!mouse!model!with! conditional! βXcatenin! loss! of! function! in! endothelial! cells!which! leads! to!
immature!BBB!(Liebner!et!al.!2008).!Plvap!is!also!upregulated!in!retinal!endothelial!cells!of!Lrp5X/X!
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and! Tspan12X/X! mice! (Junge! et! al.! 2009)! and! in! pathological! conditions! such! as! Alzheimer’s!
disease,! brain! tumors,! and! stroke! (CarsonXWalter! et! al.! 2005,! Sparks! et! al.! 2000).! PLVAP!
upregulation! is! also! triggered! by! activation! of! the! Erk1/2! MAPK! pathway! (Stan! et! al.! 2004).!
Further,!Claudin5! is!downregulated!in!Ndpy/X!mice!which!is!a!major!protein!of!tight!junctions!of!
endothelial!cells!and!is!involved!in!barrier!function!(Amasheh!et!al.!2005,!Schaefer!et!al.!2009).!
Claudin5! is! also!downregulated! in!Lrp5X/X!mice! (Chen!et!al.!2012).!Additionally! the! leakiness!of!
the!blood!vessels!could!also!be!due!to!diminished!mural!cell!coverage!of!the!retinal!vasculature!
in!the!Ndpy/X!mice!(Ye!et!al.!2009,!Zuercher!et!al.!2012).!Further,!Fzd4!is!expressed!in!mural!cells,!
and! therefore! NorrinXFZD4XLRP5!might! play! an! important! role! in! endothelial! cell! –!mural! cell!
interactions.!Whether!the!Norrin!dependend!leakiness!is!restricted!to!brain!derived!vessels!has!




Beside! the! development! of! the! retinal! blood! vessel! system,! Norrin! is! important! for! the!
maintenance! of! the! stria! vascularis! and! spiral! ganglion! of! the! chochlea.! The! stria! vascularis!
develops!properly! in! the!Ndpy/X!mice!but!progressively!degenerates!over! time.! In!severe!cases,!
this!blood!vessel!system!is!almost!completely!degenerated!(Rehm!et!al.!2002).!Ndpy/X!mice!show!
progressive!hearing!loss!and!in!advanced!stages,!a!loss!of!inner!hair!cells.!This!is!consistent!with!
the!human!ear!phenotype,! since!almost!every!Norrie!disease!patient! suffers! from!progressive!
hearing!loss,!sometimes!earlier!and!sometimes!later!in!life!with!the!median!age!of!onset!of!12!






Norrin! and! FZD4!play! also! an! important! role! in! the! vascularization!of! the! cerebellum.! In! both!
Ndpy/X! and! Fzd4X/X! mice,! progressive! reduction! of! the! vascular! density! and! integrity! in! the!
cerebellum! was! described! similar! to! the! retinal! vasculature! (Luhmann! et! al.! 2008,! Xu! et! al.!
2004).!But!no!alterations!were!detected! in! the!amount!of!Purkinje!and!granular!cells! in!Ndpy/X!
mice,! whereas! in! Fzd4X/X! mice! neuronal! degeneration! of! Purkinje! and! granular! cells! was!
observed.!Interestingly,!in!humans!cognitive!impairment!has!only!been!detected!in!patients!with!
a! mutation! in!NDP! but! not! in! FZD4.! Therefore! mouse! and! human! data! are! to! some! extend!
contradictory! regarding! the! involvement! of! Norrin/FZD4! signaling! in! the! development! of! the!
vasculature!in!the!cerebellum.!Further!it!is!not!clear!whether!Norrin!is!involved!in!BBB!formation!




Norrin! is! also! important! for! the! development! of! the! embryonic! vasculature.! When! Norrin! is!
ubiquitous!overexpressed!in!early!embryogenesis,!a!severe!disruption!in!angiogenesis!and!midX
gastational! lethality! was! observed,! which! was! fully! suppressed! in! a! Fzd4X/X! background! and!
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partially!supressed!in!LRP5X/X!background!(Ye!et!al.!2009).!FZD4!seems!to!be!the!major!receptor!





mice! homozygous! for! the!Ndp! knockout! allele! are! almost! completely! infertile! (Kaloglu! et! al.!
2011,!Luhmann!et!al.!2005b).!Pregnant!NdpX/X!females!show!defects!in!the!vascularization!of!the!
decidua! and! in! decidualization,! leading! to! embryo! resorption! and! an! increased! bleeding!
tendency! starting! at! E! 7! (Luhmann!et! al.! 2005b). Infertility! has! also!been! reported! for!Fzd4−/−!
mice,!which!show!an!insufficiency!of!their!ovaries!(Hsieh!et!al.!2005).!Thus!Norrin!is!suggested!to!
play!a!role! in! the!vascular!development!of! the! female!reproductive!tract,!but!whether!FZD4! is!
involved!in!the!same!mechanism!or!other!receptors!are!important!in!this!setting!is!not!known.!
!
Norrin’s! proangiogenic! function! has! also! been! demonstrated! in0 vitro.! Recombinant! human!





Beside! the! vascular! function,! a! neuroXprotective! function! was! described! for! Norrin.! In!Ndpy/X!
mice,!a!loss!of!RGCs!was!observed!(Richter!et!al.!1998).!This!might!be!a!direct!effect!of!Norrin,!
rather! than! a! secondary! effect! due! to! the! defective! retinal! vasculature.! Norrin! protects! RGC!
death!in!a!RGC!degeneration!model!induced!by!NXmethylXDXaspartate!(NMDA)!(Seitz!et!al.!2010).!
In! eyes! treated!with!Norrin! and!NMDA,! an! increased! retinal! expression! of! leukemia! inducible!
factor! (Lif),! endothelinX2! (Edn2),! fibroblast! growth! factorX2! (Fgf2),! brainXderived! neurotrophic!
factor!(Bdnf),!lens!epitheliumXderived!growth!factor!(Ledgf)!and!ciliary!neurotrophic!factor!(Cntf)!
was!detected!compared!to!NMDA!treated!eyes!(Seitz!et!al.!2010).!Further,!cultured!Müller!glia!
cells! release! neurotrophic! factors! upon! Norrin! treatment! and! a! direct! and! indirect! neuroX
protective! effect! of! Norrin! on! RGCX5! survival! was! shown! (Seitz! et! al.! 2010).! RGCX5! cells! have!
recently!been!shown!to!be!of!mouse!instead!of!rat!origin!and!do!not!express!RGC!markers,!RGCX
5!cells!rather!represent!a!lineage!of!mouse!neuronal!precursor!cells!than!rat!RGCs!(Van!Bergen!
et! al.! 2009).! Another! study! showed! a! neuroXprotective! effect! of! Norrin! on! RGCX5! cells! by!
attenuating! tissue! plasminogen! activator! (tPA)! and! urokinase! plasminogen! activator! (uPA)X
mediated! cell! death! (Lin! et! al.! 2009).! This! neuroXprotective! function! of! Norrin! is! mediated!







suggest! a! transplacental! effect! of! Norrin! on! the! embryo.! In! Xenopus,! maternal! xNorrin! is!
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upstream! of! neuronal! inducers! like! Chordin,!Noggin,! and! Xnr3! and! promotes! anterior! neural!







Wnt! signaling! is! a! very! well! known! signaling! pathway! involved! in! many! processes! during!
embryonic!development,!adult!homeostasis!and!diseases.! In!particular,!Wnt!signaling! is!crucial!
in! early! embryonic! patterning! by! the! regulation! of! cell! fate! decisions,! tissue! polarity! and! cell!
movements!(McMahon!and!Moon!1989).!Aberrant!Wnt!singaling!has!been!implicated!in!various!









secreted! glycoproteins,! which! bind! to! the! extracellular! cysteineXrich! domain! of! the! seven!
transmembrane! domain! cell! surface! receptors! of! the! FZD! receptor! family.! In! canonical! Wnt!




In! the! absence! of!Wnt! ligands,! a! large! cytoplasmic! complex! that! includes! Axin,! adenomatous!



















binds! bone! morphogenic! protein! 4! (Bmp4)! and! inhibits! the! activity! of! Bmp4! and! vice! versa.!
Therefore,!xNorrin!and!Bmp4!are!reciprocal!inhibitors.!xNorrin!inhibits!Activin/Nodal!activity!and!




SHORT! syndrome! and! anophthalmiaXmicrophthalmia,! retinal! dystrophy,! myopia,! polyX! and/or!
syndactyly,! and! brain! anomalies! (Bakrania! et! al.! 2008,! Reis! et! al.! 2011).! Inhibition! of! BMP4!
signaling!has!also!been!asocciated!with!primary!openXangle!glaucoma!(POAG)!(Wordinger!et!al.!
2007).!!
The! effect! on! Wnt! and! TGFXβ! signaling! of! three! known! Norrin! mutations! (p.Arg40Lys,!
p.Leu60Pro,!and!p.Lys57Asn)!associated!with!human!phenotypes!was!investigated!and!revealed!
interesting! results! (Xu! et! al.! 2012).! Two!mutations! (p.Arg40Lys,! p.Leu60Pro)! showed! reduced!
and! one! mutation! (p.Lys57Asn)! strong! increased! activation! of! Wnt! target! gene! expression,!
which! is! consistent! with! previous! findings! (Smallwood! et! al.! 2007).! The! same!mutations! had!
different!effects!on!the!TGFXβ!target!gene!Xbrachyury!(Xbra),!a!mesoderm!marker.!The!xNorrin!
p.Arg40Lys! mutant! largely! inhibited! Xbra! expression,! while! the! xNorrin! p.Leu60Pro! mutant!
showed!only! slight! inhibitory!activity.!But! the! xNorrin!p.Lys57Asn!mutant! completely! failed! to!
suppress! Xbra! expression.! Norrin! is! a! very! small! protein! but! it! is! capable! of! inducing! and!
inhibiting! two! different! pathways! at! the! same! time.! How! this! is! achieved! is! not! known.! The!
threeXdimensional! structure! of! Norrin! and! its! binding! partners,! in! the! wild! type! and! mutant!
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We! have! evidence! that! also!MAPK! signaling! is! implicated! in! Norrie! disease! pathogenesis! and!





compared! to! cells! expressing! a! mutant! (p.Cys95Arg)! rhNorrin! variant! (Zuercher! et! al.! 2012).!
Further,! several!mouse!models! with! a! defective!MAPK! signaling! pathway! have! similar! retinal!
vascularization!phenotypes!as!it!can!be!seen!in!the!Ndpy/X!mice!(personal!communication,!Prof.!
A.! Nordheim).! One! of! these!MAPK! signaling! components! is! the! serum! response! factor! (SRF),!
which! is! a! transcription! factor! that! controls! the! expression! of! cytoskeletal! proteins! and!
immediate!early!genes! in!different!cell! types! (Knoell!and!Nordheim!2009).! SRF! is!expressed! in!
endothelial! cells! (ECs)! of! capillaries! in! the!mouse! embryo! and! lead! in! an! endothelialXspecific!
knockout! model! to! reduced! capillary! density,! aneurysms,! and! heamorrhages! (Franco! et! al.!




The!genes,!which!were! screened! for!mutations! in!patients!with! severe! retinal! dysplasia,!were!
selected!due! to!different! reasons.! I!would! like! to! introduce! these! genes! and! the! reasons!why!
they!were!selected!for!mutation!screening!briefly.!
1.7.1!ATOH7!–!a!transcription!factor,!required!for!proper!retinogenesis!
A! deletion! in! a! remote! enhancer! of! ATOH7! was! reported! in! patients! with! a! similar! eye!
phenotype!like!Norrie!disease!(Ghiasvand!et!al.!2011).!Thus!we!screened!ATOH7! in!our!cohort.!




The! nerve! injury! induced! protein! 1! (NINJ1,! Ninjurin1)! is! an! adhesion! molecule! on! the! cell!
surface,!which!plays!a!role!in!vascular!remodeling!(Lee!et!al.!2009).!Its!name!derives!from!its!role!
in! the! peripheral! nervous! system! where! it! is! induced! by! nerve! injury! and! promotes! axonal!
growth! (Araki! et! al.! 1997,! Araki! and! Milbrandt! 1996).! NINJ1! is! ubiquitously! expressed! in! all!
tissues! with! epithelial! origin.! In! addition,! NINJ1! is! strongly! expressed! in! myeloid! cells! and!
partially!expressed! in!endothelial!cells.! Its! role! in!vascular! remodeling!and!the!central!nervous!











The! group! of! Prof.! Frans! Cremers! (Department! of! Human! Genetics,! Radboud! University!
Nijmegen! Medical! Centre)! performed! linkage! analysis,! exome! sequencing,! and! segregation!
analysis!of!DNA!variants! in!one!Dutch!FEVR!family!and! identified! two!putative!diseaseXcausing!
DNA!variants! in!PASK! (c.791dup;!p.Ser265ValfsX64)!and!ZNF408! (c.1363C>T;!p.His455Tyr).! The!
second!sequence!variant!was!also!present!in!an!additional!Dutch!FEVR!family!that!subsequently!
appeared!to!share!a!common!ancestor!with!the!original!family.!ZNF408!is!a!transcription!factor!







Ndpy/X! mouse! model.! Prof.! Ralf! Adams! (MaxXPlanck! Institute! for! Molecular! Biomedicine,!
Münster,! Germany)! contacted! us! regarding! this! project.! We! screened! our! patient! cohort! for!
mutations!in!these!genes.!This!collaboration!is!still!ongoing!and!already!revealed!very!interesting!
results.!
ILK! is! a!multifunctional! intracellular! effector! of! cellXmatrix! interactions.! It! is! localized! at! focal!
adhesion! (FA)! complexes! and! is! a! serine/threonine! protein! kinase! that! regulates! cell!
proliferation,!migration,!and!survival! (Fielding!et!al.!2008,!McDonald!et!al.!2008).! ILK!mediates!
extracellular! signals! over!membrane! bound! integrins! to! the! actin! cytoskeleton.!We! think! that!
there! might! be! a! link! between! ILK,! Norrin,! and! planar! cell! polarity! (PCP)! signaling.! Besides!
canonical!Wnt!signaling,!Norrin!might!also!be!implicated!in!the!PCP!pathway.!The!PCP!pathway!
mediates! asymmetric! cytoskeleton! organization! and! the! polarization! of! cells! by! inducing!
modifications!to!the!actin!cytoskeleton.!ILK!is!implicated!in!vascular!development!and!leukocyte!
recruitment! (Friedrich! et! al.! 2002,! Friedrich! et! al.! 2004,! VouretXCraviari! et! al.! 2004).! It! is! also!
involved!in!the!vascular!smooth!muscle!cell!coverage!and!vascular!wall!formation,!regulated!by!
the!Rho/ROCK!signaling!(Ho!and!Bendeck!2009,!Kogata!et!al.!2009).!!
Integrins! are! transmembrane! proteins! and! the!main! cell! adhesion! receptors! involved! in! focal!
adhesion.!They!mediate!attachment!to!the!actin!cytoskeleton!and!are! involved! in! transmitting!
signals! from! the! extracellular! space! inside! of! the! cell.! Integrins! are! heterodimeric! receptors!
composed!of!an!alpha!and!a!beta!subunit.!Different!combination!of!alpha!and!beta!subunits!can!
bind! different! extracellular! molecules! and! attach! cells! to! the! extracellular! matrix through!
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lead! to! a! similar! retinal! vascular! phenotype! like! EVR! in! humans.! Therefore! we! screened! our!
cohort!for!mutations!in!SRF,!MKL1!and!MKL2.!!
SRF!is!a!member!of!the!MADS!(MCM1!agamous!deficiens!SRF)!box!family!of!transcription!factors!




angiogenesis! and! vascular! integrity! (Chai! et! al.! 2004,! Franco! et! al.! 2008).! SRF! links! nuclear!





molecules! to! the! monomeric! GXactin! in! the! cytoplasm.! Upon! serum! induced! actin!
polymerization,!MKL1!and!MKL2!accumulate! in! the!nucleus! (Vartiainen!et!al.!2007).!Mice!with!
endothelialXspecific! ablation!of! serum! response! factor!develop!normally!until! E!10.5!but! then,!













(3) To! investigate! if! Norrin! is! associated! with! the! extracellular! matrix! (ECM)! and! if!
glycolysation!of!the!protein!occurs!
(4) Structural!analysis!of!Norrin!by!XXray!crystallography!
(5) Isolation!of! retinal!endothelial!cells! (RECs)! from!wild! type!and!Ndpy/X!mouse!retinae!to!
stimulate!them!with!recombinant!Norrin!and!VEGF!














































































































































































































































































of! Zurich! or! to! the! Developmental! Neurogenetics! Clinic! at!Massachusetts! General! Hospital! at!
Harvard! University! in! Boston! for! diagnostic! purposes.! Informed! consent! according! to! the!
declaration! of! Helsinki! or! applicable! Swiss/US! law!was! obtained! from! all! subjects! involved! in!
genetic!testing.!DNA!samples!were!extracted!from!EDTA!blood!or!saliva!samples.!Saliva!samples!
were! collected! with! OraGene™! Kit! (DNA! Genotek,! Ottawa,! Canada).! DNA! extraction! was!
performed! in! the! diagnostic! division! of! the! Institute! of!Medical!Molecular! Genetics! by! semiX
automated!DNA!extraction!robot!(chemagic!MSMI,!Chemagen,!Baeseiler,!Germany)!or!approved!
foreign!diagnostic! laboratories! sent!purified!DNA! to!us.!All! samples!obtained!an! identification!
(ID)!number! in!order!to!anonymize!personal!data.!Patients! in!this!cohort!are! from!all!over!the!











Plasmid!DNA!was! isolated!according! to!manufacturer’s! instruction!with!a! columnXbased!kit!by!
hand!or!with!a!robot!(BioRobot!9600,!Quiagen)!if!more!than!16!samples!had!to!be!isolated!at!the!










Tris,!pH!7.5! 50mM! 5ml! 1M!
NaCl! 150mM! 3ml! 5M!
sodium!deoxycholate! 0.50%! 0.5g! !
SDS!(sodium!dodecyl!sulphate)! 0.10%! 0.1g! !
Trition!XX100! 1.00%! 1ml! !
complete!protease!inhibitors! 1!tablette! ! !







Phenol! Chloroform! extraction! was! used! to! obtain! highly! pure! DNA! without! protein!
contaminations.!This! technique!was!also!used!to! isolate!DNA,!RNA!and!protein! from!the!same!
















































Primers!were! designed! using! the!webXbased! program! Primer3! (v0.4.0).! Primer! specificity!was!







The! PCR! products! (amplicons)! were! separated! by! size! using! agarose! gel! electrophoresis.!



















TrisXbase! 242g!  Ficoll®!400! 7.5g!
Glacial!acetic!acid! 57.1ml!  Bromphenol!blue! 0.25g!
EDTA!0.25M!pH!8.0! 200ml!  EDTA!0.5M!pH!8.0! 1ml!
ddH2O! add!1000ml!  Glycerol! 12.5ml!





DNA! and! sequenced! afterwards.! An! overview! of! all! genes! is! listed! in! Table! 4,! primers! in!
Appendix! C.! The! PCR! conditions! for! each! amplicon!were! established! by! using! a! control! DNA.!




Gene! Gene!ID! Strand! Transcript!ID!(Ensemble)! Lenght!(bp)! Lenght!(aa)! Ch.!
ATOH70 ENSG00000179774! reverse! ENST00000373673! 1486! 152! 10!
NEUROD10 ENSG00000162992! reverse! ENST00000295108! 2852! 356! 2!
ZNF4080 ENSG00000175213! forward! ENST00000311764! 2442! 720! 11!
ILK0 ENSG00000166333! forward! ENST00000299421! 1802! 452! 11!
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PARVA0 ENSG00000197702! forward! ENST00000334956! 4458! 412! 11!
ITGB30 ENSG00000259207! forward! ENST00000262017! 4894! 788! 17!
SRF0 ENSG00000112658! forward! ENST00000265354! 4200! 508! 6!
MKL10 ENSG00000196588! reverse! ENST00000355630! 4496! 931! 22!
MKL20 ENSG00000186260! forward! ENST00000318282! 8608! 1049! 16!
NDP0 ENSG00000124479! reverse! ENST00000378062! 1833! 133! X!






! ! ! ! ! ATOH7!Exon1_10 !
ATOH7!Exon1_1# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
360!Master!Mix! !! 12.5µl! !! ! 95°C! 10min!
360!GC!Enhancer! !! 5µl! !! ! 95°C! 1min! !
Primer!fwd! 10µM! 1µl! 500nM! ! 60°C! 1min! 35x!
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 2min! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! 72°C! 10min! !
ddH2O! !! 4.5µl! !! ! 10°C! ∞! !
Total! !! 25µl! !! ! ! ! !
! ! ! ! ! ATOH7!Exon1_20 !
ATOH7!Exon1_2# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2.5µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.5µl! 1.8mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 200µM! ! 60°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.3µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1.3µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 14.65µl! !! ! ! ! !
SXSolution! 10x! 2.5µl! 1x! ! ! ! !
Total! !! 25µl! !! ! ! ! !
Table!5:!PCR!and!cycling!conditions!for!amplification!of!exon!1!of!the!ATOH7!gene.!
NEUROD1#
! ! ! ! ! NEUROD1!Exon20 !
NEUROD1# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2.5µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.5µl! 1.8mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 200µM! ! 60°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.3µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1.3µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 14.65µl! !! ! ! ! !
SXSolution! 10x! 2.5µl! 1x! ! ! ! !




! ! ! ! ! ZNF408!Exon!10 !
ZNF408!Exon!1# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min!
dNTPs! 20mM! 0.2µl! 200µM! ! 61°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.1µl! 0.025U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! !
ddH2O! !! 13.5µl! !! ! ! !
Total! !! 20µl! !! ! ! ! !
! ! ! ! ! ZNF408!Exon!2,!5B,!5C,!5D0
ZNF408!Exons!2,!5B# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 2µl! 2.5mM! ! 95°C! 45s! !
dNTPs! 20mM! 0.2µl! 200µM! ! 60°C! 1min! 40x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 1.5min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 12.6µl! !! ! ! ! !
Total! !! 20µl! !! ! ! ! !
!!! ! ! ! ! ZNF408!Exon!3,!4,!5A!
ZNF408!Exons!3,!5A,!5C,!5D# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.2µl! 200µM! ! 60°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.4µl! !! ! ! ! !
Total! !! 20µl! !! ! ! ! !
! ! !! ! ! ! ! !
ZNF408!Exon!4# Stock!conc.! Vol.! Final!conc.! ! ! ! !
Buffer!B! 10x! 2µl! 1x! ! ! ! !
MgCl2! 25mM! 2µl! 2.5mM! ! ! ! !
dNTPs! 20mM! 0.2µl! 200µM! ! ! ! !
Primer!fwd! 10µM! 1µl! 500nM! ! ! ! !
Primer!rev! 10µM! 1µl! 500nM! ! ! ! !
HotFire™!Polymerase! 5U/µl! 0.1µl! 0.025U/µl! ! ! ! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 12.7µl! !! ! ! ! !





!  ! ! ! ILK!Exon!2X130 !
ILK# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2.5µl! 1x! ! 95°C! 15min! !
MgCl2! 25mM! 1.5µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 200µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.3µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 17.45µl! !! ! ! ! !




! ! ! ! PARVA!Exon!1X10,!12,!130
PARVA!Exon!1C10,!12,!13# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min! !
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 45s! !
dNTPs! 20mM! 0.2µl! 200µM! ! 52°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 1.5min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.4µl! !! ! ! ! !
Total! !! 20µl! !! ! ! ! !
! ! ! ! PARVA!Exon!110 !
PARVA!Exon!11# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min! !
MgCl2! 25mM! 1.6µl! 2.0mM! ! 95°C! 45s! !
dNTPs! 20mM! 0.2µl! 200µM! ! 64°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 1.5min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.2µl! !! ! ! ! !














!  ! ! ! ITGB3!Exon!2X150 !
ITGB3!Exon!2C15# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min! !
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.2µl! 200µM! ! 60°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 11.4µl! !! ! ! ! !
SXSolution! 10x! 2µl! 1x! ! ! ! !
Total! !! 20µl! !! ! ! ! !
Table!10:!PCR!and!cycling!conditions!for!amplification!of!exon!2X15!of!the!ITGB3!gene.!
SRF#
    ! SRF!Exon!2X70 !
SRF# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2.5µl! 1x! ! 95°C! 15min! !
MgCl2! 25mM! 1.5µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 200µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !!
HotFire™!Polymerase! 5U/µl! 0.3µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 17.45µl! !! ! ! ! !
Total! !! 25µl! !! ! ! ! !
Table!11:!PCR!and!cycling!conditions!for!amplification!of!exon!2X7!of!the!SRF!gene.!
MKL1#
    ! MKL1!Exon!1X9,!12X15!0 !
MKL1# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.2µl! 200µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.4µl! !! ! MKL1!Exon!10!0 !
Total! !! 20µl! !! Cycling!conditions!
    ! 95°C! 15min!
     95°C! 1min!
     60°C! 1min! 35x!
     72°C! 2min! !
     72°C! 10min! !





    ! MKL2!Exon!1X160 !
MKL2!Exon!2C5,!7C16# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.2µl! 200µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.4µl! !! ! ! ! !
Total! !! 20µl! !! ! ! ! !
    !  !  
MKL2!Exon!1,!6# Stock!conc.! Vol.! Final!conc.! !  !  
Buffer!B! 10x! 2µl! 1x! !  ! !
MgCl2! 25mM! 1.6µl! 2mM! !  ! !
dNTPs! 20mM! 0.2µl! 200µM! !  !  
Primer!fwd! 10µM! 1µl! 500nM! !    
Primer!rev! 10µM! 1µl! 500nM! !    
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! !    
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! !    
ddH2O! !! 13.4µl! !! ! ! ! !






! ! ! ! ! NDP!Exon!1X30 !
NDP!Exon!1,!2,!3# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.2µl! 1.5mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 250µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 1.5min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.2µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 13.35µl! !! ! ! ! !












! ! ! ! ! TAPAN120Exon1X7,8.1,8.20
TSPAN12# Stock!conc.! Vol.! Final!conc.! ! Cycling!conditions!
Buffer!B! 10x! 2.5µl! 1x! ! 95°C! 15min!
MgCl2! 25mM! 1.5µl! 1.8mM! ! 95°C! 1min! !
dNTPs! 20mM! 0.25µl! 200µM! ! 58°C! 1min! 35x!
Primer!fwd! 10µM! 1µl! 500nM! ! 72°C! 2min! !
Primer!rev! 10µM! 1µl! 500nM! ! 72°C! 10min! !
HotFire™!Polymerase! 5U/µl! 0.3µl! 0.05U/µl! ! 10°C! ∞! !
DNA!template! 50ng/ul! 1µl! 2.5ng/µl! ! ! ! !
ddH2O! !! 17.45µl! !! ! ! ! !




Unincorporated!dNTPs!and!primers,!which!could! interfere!with! the! sequencing! reaction,!were!
removed!by!the!ExoSAPXIT®!PCR!clean!up!method!(USB,!Cleveland,!OH,!USA)!whenever!required.!
It! is!based!on!Exonuclease! I! (Exo)!and!Shrimp!Alkaline!Phosphatase! (SAP),!Exo!digests! residual!
singleXstranded! primers! or! any! other! single! stranded! DNA! fragments,! and! SAP! removes!
phosphate! groups! of! dNTPs! to! prevent! their! incorporation.! 5µl! of! ExoSAPXIT®! (diluted! 1:50! in!











(Sanger! et! a.! 1977).! By! random! incorporation! of! fluorescently! labeled! dideoxynucleotides!
(ddNTPs)!into!the!DNA!strand!during!amplification!further!elongation!is!inhibited.!When!ddNTPs!
are! mixed! with! an! excess! of! dNTPs,! a! heterogenous! population! of! fragments! of! all! possible!
lengths! is! generated,! all! ending! with! a! fluorescently! labeled! nucleotide.! Each! of! the! four!




additional! internal! sequencing! primers! were! used,! as! indicated! in! the! primerXcollection!
(Appendix!C).!The!sequencing!reaction!was!purified!with!Sephadex!GX50!(SigmaXAldrich,!Buchs,!








Cycle!sequencing! Vol.! ! Cycling!conditions!
Sequencing!buffer!5x! 1.6µl! ! 96°C! 1min! !
PCR!Product! 1µl! ! 96°C! 20s! !
Primer!! 1µl! ! 50X58°C! 10s! 25x!
BigDye™! 0.8µl! ! 60°C! 2min! !
ddH2O! 5.6µl! ! 10°C! ∞! !
Total! 10µl! ! ! ! !
Table!17:!Cycle!sequencing!mix!and!reaction.!
!
The! results!were! analyzed! using! the! softwares! Sequencing! Analysis! 5.2,! SeqScape! version! 2.5!
(both! Life! Technologies,! Zug,! Switzerland)! and! Sequence! Pilot! 3.1! (JSI!Medical! System!GmbH,!




To! analyze! the! effect! of! a! specific! mutation! on! the! function! of! the! particular! protein,! an!
expression! construct! for! each! mutation! was! generated.! The! wild! type! ORF! of! the! gene! of!
interest! had! to! be! present! in! any! kind! of! vector.! The! wild! type! sequence! of! each! ORF! was!
verified!by!direct!sequencing!in!the!respective!expression!vector.!When!the!wild!type!sequence!
was!confirmed,!two!PCRs!were!performed!using!the!wild!type!sequence!as!a!template!(Figure!9).!
The! first! PCR! with! a! forward! primer! at! the! start! codon! of! the! gene! (with! an! addition! of! the!
sequence! CACC,! for! Gateway! cloning! using! pENTR™/DXTOPO®! cloning! kit)! and! the! reverse!
primer!was! at! the! position!where! the!mutation! had! to! be! inserted.! For! the! second! PCR,! the!
forward!primer!was!at!the!position!of!the!mutation!and!the!reverse!primer!at!the!stop!codon.!
After!the!naturally!occurring!stop!codon,!two!additional!stop!codons!were!integrated!to!ensure!




When!a! single!distinct!band!with! the!expected! size!was!detected! in! the!agarose!gel,! a! simple!
removal!of!primers!by!PCR!cleanXup!(NucleoSpin®!Extract!II!kit!of!MacheryXNagel)!was!sufficient!
for! further! use!of! the! generated! amplicon.! The! two! long!primers! at! the!mutation! site! had! an!
overlapping!sequence!of!20bp!to!link!the!two!amplicons!together!in!third!PCR.!Depending!on!the!
size!of!the!two!amplicons,!the!amplicon!amount!was!adjusted,!so!that!similar!amounts!of!each!
amplicon!were!present! in! the! third!PCR.!A! total!amount!of!500ng!DNA,! the! forward!Primer!of!
the!first!amplicon!and!the!reverse!primer!of!the!second!amplicon!were!used!in!the!third!PCR!to!







Mutagenesis!PCR!1!&!2! Stock!conc.! Vol.! ! ! Cycling!conditions!(PCR1&PCR2)!
Pfu!Buffer!10x! 10x! 5µl! ! ! 95°C! 2min! !
dNTPs! 20mM! 0.4µl! ! ! 95°C! 45s! !
Primer!fwd! 10µM! 1µl! ! ! 42°C! 30s!  
Primer!rev! 10µM! 1µl! ! ! 72°C! 3.5min! !
Pfu™!Polymerase! 3U/µl! 1µl! ! ! 95°C! 45s! !
DNA!template!(vector)! 100ng/ul! 1µl! ! ! 46°C! 30s! !
ddH2O! !! 40.6µl! ! ! 72°C! 3.5min! !
Total! !! 50µl! ! ! 95°C! 45s! !
! ! ! ! ! 58°C! 30s! 35x!
! ! ! ! ! 72°C! 3.5min! !
! ! ! ! ! 72°C! 10min! !
! ! ! ! ! 10°C! ∞! !
Table!18:!Mutagenesis!PCR!and!cycling!conditions!for!amplicons!1!&!2.!
!
Mutagenesis!PCR!3! Stock!conc.! Vol.! ! ! Cycling!conditions!(PCR3)!
Pfu!Buffer!10x! 10x! 5µl! ! ! 95°C! 2min! !
dNTPs! 20mM! 0.4µl! ! ! 95°C! 45s! !
Primer!fwd! 10µM! 1µl! ! ! 62°C! 30s! 4x!
Primer!rev! 10µM! 1µl! ! ! 72°C! 3.5min! !
Pfu™!Polymerase! 3U/µl! 1µl! ! !    
DNA!of!PCR1&PCR2!(500ng)! 100ng/ul! 5µl! ! ! 95°C! 45s! !
ddH2O! !! 36.6µl! ! ! 58°C! 30s! 29x!
Total! !! 50µl! ! ! 72°C! 3.5min! !
! ! ! ! ! 72°C! 10min! !
! ! ! ! ! 10°C! ∞!  
Table!19:!Mutagenesis!PCR!and!cycling!condition!for!amplicon!3.!
!




Cloning! was! performed! using! different! approaches.!When! ever! possible! the! Gateway! cloning!
system!(Life!Technologies,!Zug,!Switzerland)!was!used.!This!system!allows!directional!bluntXend!
cloning.! I! used! the! pENTR™/DXTOPO®! cloning! kit! with! OneShot! TOP10! chemically! competent!
cells!(Life!Technologies,!Zug,!Switzerland).!With!the!pENTR™/DXTOPO®!vector!it!is!possible!to!go!




lab! incubator! shaker! (Innova™!4400;!New!Brunswick! Scientific,! Edison,!NJ,!USA).!Plasmid!DNA!
was!extracted!from!each!culture!with!NucleoSpin®!Plasmid!Kit!from!MacheryXNagel.!A!glycerole!








Bacto!Tryptone! 10g!  Bacto!Tryptone! 10g!
Bacto!Yeast!extract! 5g!!  Bacto!Yeast!extract! 5g!!
NaCl! 10g!  NaCl! 10g!
ddH2O! add!1000ml!  Bacto!Agar! 15g!
autoclave! !!  ddH2O! add!1000ml!
! !  autoclave! !!
Table!20:!LB!Medium!and!LB/Agar!for!E.coli!cultivation!
!
To! identify! pENTR™/DXTOPO! clones! with! an! insert! of! the! correct! size,! 2µl! vector! DNA! was!
digested! in! a! 10µl! approach! with! Tango! buffer! using! NotI! and! SgsI! restriction! enzymes!
(Fermentas,! St.LeonXRot,! Germany)! for! 2h! at! 37°C.! Reaction! was! loaded! on! an! agarose! gel.!
Clones!with!insert!of!correct!size!were!sequenced.!
!























To! verify!whether! a! gene! is! transcribed! in! a! certain! tissue! or! cell! line,! RNA!was! isolated! and!
reverse!transcribed!as!described!before.!For!each!gene!of! interest,!two!exon!spanning!primers!
were! designed! to! generate! an! amplicon! of! 150X250bp,! specific! for! the! gene! of! interest.!




































A! major! goal! during! this! thesis! was! to! get! hands! on! recombinant! human! Norrin! for! use! in!
functional!assays.!For!this,!stably!Norrin!(either!wild!type!or!diseaseXassociated!mutant!isoforms)!
expressing! cell! lines! were! established.! This! was! done! during! my!Master! thesis! 2006X2007.! A!
schematic! representation!of! the! constructs!used! for! the!generation!of! these! sable! cell! lines! is!
indicated!in!figure!10.!The!pBud!CE4.1!vector!(Life!Technologies,!Zug,!Switzerland)!with!a!CMV!
promoter!was!used!to!transfect!HEK293T!cells.!Stable!gene!expression!technology!was!used!in!a!











Figure! 10:! Schematic! representation!of!Norrin! constructs.!hNDP! sequence! (light! green),! signal! peptide!
(dark!green),!RGS! (light!blue),!myc!tag! (blue),! linker! (light!blue),!polyhistidine!tag! (dark!blue).!The!hNDP!
sequence! and! the! signal! peptide! have! been! cloned! site! directed! into! a! pBud! CE4.1! vector! (Life!
Technologies),!myc!and!polyhistidine!(6xHis)!tags!derive!from!vector!sequence.!
!
Beside! the! wild! type! human! Norrin,! four! diseaseXassociated! mutant! isoforms! were! used! to!























reduced! in! an! early! stage,! which! simplifies! the! whole! downstream! purification! processe.!
Additionally!the!protein!production!costs!are!diminished!significantly.!To!minimize!clumping!of!
the! suspension! cells,! heparin!was! added! to! the! cell! culture!medium,!which! also! increases! the!
solubility!of!Norrin.!SuspensionXadapted!HEK293T!cells!were! routinely!grown! in!75cm2!TXflasks!
stand!upright! in!100!mL!of! serumXfree!DMEM!supplemented!with!LXglutamine,!5000E!Heparin!
and! 50mM! sodium! chlorate.! Stably! Norrin! expressing! cells! were! grown! to! high! densities! by!
carefully!monitoring!cell!viability!using!trypan!blue!staining.!Suspension!cells!with!viability!higher!
than!approximately!90%!were!used!to!inoculate!the!production!medium.!3X5!x105!cells/mL!were!







Purification! of! native! Norrin! was! either! performed! using! immobilized! metal! affinity!
chromatography! (IMAC)! or! heparin! chromatography! (Porath! et! al.! 1975,! Hochuli! et! al.! 1987,!
Farooqui! 1980).! For! the! IMAC! approach! a! CXterminal! polyhistidine! (6x! His)! tag! was! used! for!
protein!capturing.!For!the!heparin!approach!other!protein!characteristics,!in!particularly!the!high!
content!of!basic!amino!acids! in!Norrin,!was! taken! in!advantage.!Also!a! combinatory!approach!
was!tried.!During!my!master!thesis!I!established!stably!Norrin!expression!cell!lines!and!showed!
that! recombinant! human!Norrin! can! be! purified!with! IMAC! in! a! batch! setup.! During!my! PhD!
thesis! I! established! the!purification!on!an!ÄKTA!purifier! system!using!UNICRON™!5.11! control!
software! (both!Amersham!Biosciences/GE!Healthcare!Europe,!Otelfingen,! Switzerland).!During!
my! PhD! thesis! I! further! selected! high! expressing! clones! to! get! higher! recombinant! protein!
amounts.!I!also!optimized!growth!conditions!and!purification!strategy.!Therefore!I!used!different!















Preparation! of! medium! prior! to! purification! is! important! to! minimize! backpressure! on!
purification! columns! and!maximize! lifetime! of! the! columns.! To!minimize! backpressure! on! the!









binding!buffer! to! add!10X40mM! imidazole! that! prevents! unspecific! binding!of! proteins! to!Ni2+!
ions.!Prior! sample! loading!column!was!equilibrated!using!5X10!column!volumes! (CV)!of!ddH2O!
followed! by! 5X10! CV! of! 1x! IMAC! binding! buffer.! 1mL! or! 5mL! HisTrap™! FF! crude! column!was!
loaded!with!up!to!100mL!or!500mL!cell!culture!medium/binding!buffer!using!a!peristaltic!pump.!
The!column!was!then!connected!to!the!ÄKTA!purifier!system!and!washed!with!wash!buffer!for!
approximately! 20! CV! or! till! A280! baseline! was! reached! again,! which! indicates! that! no! more!
protein!impurities!can!be!washed!from!the!column.!Different!purification!protocols!were!tested,!







sodium!phosphate!buffer! 20mM!  sodium!phosphate!buffer! 20mM!
NaCl! 500mM!  NaCl! 500mM!
Imidazole! 20mM!  Imidazole! 20mM!







Since! elution! fractions! contain! high! concentration! of! NaCl! and! imidazole,! the! recombinant!
protein!containing! fractions!were!desalted!using!two!PDX10!(GE!Healthcare)!columns! in!series.!
Other!desalting!techniques!were!tried!as!well,! including!dialysis!and!ultracentrifugation.!PDX10!
group! separation! had! the! highest! recovery! rate! and! could! be! performed! in! less! time! then!





























NiSO4!(Stock!650mM)! 0.1M! 77.375µl!  Ni(II)!sulfate,!anhydrous!(154.8g/mol)! 10g!


















sodium!phosphate!pH!7.00! 10mM!  sodium!phosphate!pH!7.00! 10mM!




Tangential! flow! filtration! (TFF)! was! used! to! concentrate! rhNorrin! in! the! conditional! medium.!
Medium!was!filtrated!first!with!a!bottle!top!filter!and!than!filtered!through!a!500kDa!membrane.!
Filtrate! of! this! step! was! than! concentrated! on! a! 5kDa! membrane.! With! this! approach! high!































Tris/HCl,!pH!8.3! 125mM! 15.1g!  TrisXHCl!pH!6.8!! 250mM!
glycin! 200mM! 72g!  SDS!(electrophoresis!grade)! 10%!
SDS! 0.05%! 5g!  glycerol!! 50%!
ddH2O!   add!1000ml!  DDT! 200mM!
    bromophenol!blue! 0.50%!
    ddH2O! add!10ml!




Switzerland)! onto! a! polyvinylidine! difluoride! (PVDF)! membrane! (Roche! Diagnostics,! Rotkreuz,!
Switzerland).! The! PVDF! membrane! was! soaked! shortly! in! methanol! and! washed! for! 5min! in!
ddH2O.!The!wet!PVDF!membrane!and!the!SDS!gel!were! incubated!for!15min! in!blotting!buffer!
(Table! 28).! Three! chromatography! filter! papers! (Whatman®,! GE! Healthcare,! Otelfingen,!
Switzerland)!were!moistened!with!blotting!buffer!and!stacked!–!avoiding!air!bubbles!between!–!
on!the!anode!of!the!blotting!system.!The!PVDF!membrane!was!put!on!the!top!of!the!three!filter!
papers!and!covered!with! the!SDS!gel.! Three!additional!wet! filter!papers!were! stacked!on! top.!




5x!blot!buffer! 20ml!  Tris! 29.1g!
methanol! 20ml!  glycin! 14.65g!
ddH2O! add!100ml!  SDS! 1.88g!




After! blotting! the! proteins! on! the! PVDF!membrane,! unspecific! antibody! binding! was! blocked!
with! 5%!milk! powder! in! PBST! for! 2h! at! RT! shaking! on! a! laboratory! rocker!or! o/n! at! 4°C!on! a!
rotator! (Roto! –! Torque®! Heavy! Duty! rotator,! ColeXParmer! instruments,! London,! UK).! PVDF!
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membrane!was! rinsed! in! PBST! at! RT! and! incubated!with! diluted! primary! antibody! in! 5%!milk!
powder!in!PBST!for!2h!at!RT!or!over!night!at!4°C.!After!washing!four!times!for!10min!with!PBST!
at!RT!a!horse!radish!peroxidase!(HRP)!secondary!antibody!was!incubated!for!30min!–!1h!at!RT.!
The!PVDF!membrane!was!washed! six! times! for!10!min!with!PBST.! The!membrane!was!placed!
between! two! plastic! sheets! and! enhanced! chemiluminescence! (ECL)! substrate! (Western!
Lightning™!ECL!plus!system,!NEL103;!Perkin!Elmer,!Boston,!MA,!USA)!was!prepared!according!to!
the! manufacturer’s! instructions! and! added! on! the! membrane! for! 1min.! The! substrate! was!
removed!from!the!membrane,!and!the!membrane!was!placed!on!a!UVXtransilluminated!screen!








Primary!antibody! Host! Manufacturer! Dilution!
antiXcXmyc! mouse! Roche! 1:500!
antiXV5! rabbit! Sigma! 1:500!
antiXTBP! mouse! Abcam! 1:1000!
antiXtubulin! rabbit! Abcam! 1:500!
antiXMKL1! rabbit! Sigma! 1:500!
antiXGFP! rabbit! SantaCruz! 1:500!
antiXHiston!H3! rabbit! Abcam! 1:1000!
 
    
Secondary!antibody! Host! Manufacturer! Dilution!
antiXmouse!HRP! goat! Dianova! 1:2000!








Preheat!harsh! stripping!buffer! to!60°C! (Table!31).! Incubate!PVDF!membrane! for!1h!at!60°C! in!
harsh! stripping! buffer! in! a! heated! rotator! (Mini! Hybridisation! Oven,! Appligene!Watford,! UK).!
Rinse!the!membrane!under!running!tab!water!for!15min,!wash!with!PBST!for!15min.!Block!PVDF!














To! visualize! small! amounts! of! protein! (in! low!ng! range)! silver! staining!was! used.! It! is! a! rapid,!




in! at! least! 5! gel! volumes! of! a! solution! of! ethanol:glacial! acetic! acid:!water! (30:10:60)!
(Solution!1;!Fixation)!
• discard! the! fixing! solution! and! ad! at! least! 5! gel! volumes! of! 30%! ethanol;! 30min;! RT;!
gentle!shaking!(Solution!2;!Incubation)!
• repeat!step!2!






• and! ad! 5! gel! volumes! of! a! fresh! 0.1%! solution! of! AgNO3;! 30min;! RT;! gentle! shaking!
(Solution!4;!Staining)!
• wash!with!deionized!water!30s!
• ad! 5! gel! volumes! of! a! freshly! made! 2.5%! Na2CO3,! 0.02%! formaldehyde;! RT;! gentle!













EtOH! 300ml!  EtOH! 300ml!  NaS2O3.5H2O! 0.01g!
Glacial!acetic!acid! 100ml!  ddH2O! 700ml!  ddH2O! 100ml!
ddH2O! 600ml!       






AgNO3! 0.1g!  Na2CO3! 2.5g!  acetic!acid! 10ml!
ddH2O! 100ml!  formaldehyde! 40µl!  ddH2O! 990ml!





according! to! the!manufacturer’s! instructions.! SDSXPAG!was!washed! three! times! for!5min!with!
100X200ml!ddH2O.!Proteins!were!stained!with!20ml!Imperial™!Protein!Stain!solution!for!1h!with!































cell!monolayer!was! rinsed! first!with!2ml!of! iceXcold!PBS,!and!then!300µl! (per! flask)!of! iceXcold!












TrisXCl!pH!7.4! 0.01M! 1ml!of!1M!Tris!  TrisXCl!pH!7.4! 0.05M! 1ml!of!1M!Tris!
NaCl! 0.01M! 1ml!of!1M!NaCl!  glycerol!87%! 40%! 45.97ml!glycerol!
MgCl2! 0.003M! 0.3ml!of!1M!MgCl2!  MgCl2! 0.005M! 0.3ml!of!1M!MgCl2!
Triton!XX100! !! 500µl!  EDTA! 0.1mM! 0.1ml!of!100mM!EDTA!













Cultivation!of! all! cellXlines!was! conducted!under! sterile! conditions.!All! handling!was!done! in! a!
laminar!flow!hood!(biosafety!level!II),!material!was!either!packed!steril!or!cleaned!with!Barizidal!
















HEK!293T!growth!medium!  HUVEC!growth!medium!  HMECC1!growth!medium!
DMEM! 500ml!  EBMX2,complete!  M199,!complete!
FCS! 50ml!  10%!FCS!  1ml!LXglutamin!
LXglutamine! 6ml!  10!ng/ml!EGF!  1ml!Pen/Strep!
   1!µg/ml!Hydrocortisone!  1.5ml!Hepes!1M!
     20ml!FCS!




































75cm2! were! seeded! with! 6X7x! 106! cells! per! flask! in! 10ml! DMEM.! 24h! later,! when! the! cells!




removed! and! replaced! by! 5ml! of! DMEMXDNAXPEIXMix! and! incubated! for! 24h! at! 37°C! and! 5%!
CO2.!After!24h!cell!viability!and!transfection!rate!(cotransfected!GFP)!was!checked!visually!with!
an! inverted!microscope.!When! cells! reached! app.! 80%! confluence! and! transfection! efficiency!
was! higher! than! 80%! cells! were! used! for! further! experiments.! When! convluence! and!






































WSTX1! is! a! colorimetric! assay! for! the! nonradioactive! quantification! of! cell! proliferation,! cell!
viability!and!cytotoxicity.!The!soluble!and!orange!tetrazolium!salts!WSTX1!(4X[3X(4XIodophenyl)X2X
(4Xnitrophenyl)X2HX5Xtetrazolio]X1,3Xbenzene! disulfonate)! are! cleaved! to! red! formazan! by!
mitochondrial!dehydrogenases.!An!augmentation!in!enzyme!activity!leads!to!an!increase!in!the!
amount!of!formazan!dye!formed,!which!directly!correlates!to!the!number!of!metabolically!active!
cells! in! the! culture.! Quantification! of! the! formazan! dye! was! done! by! a! scanning! multiwell!
spectrophotometer.! The! absorbance! of! the! dye! was! measured! at! a! wavelength! of! 450nm!
















monolayer! of! endothelial! cells! an! artificial! gap! is! induced! by! scratching! a! wound! into! the!
monolayer!–!therefore!the!assay!is!also!called!wound!healing!assay (Liang!et!al.!2007).!The!cells!
on! the! edge! will! start! to! migrate! into! the! newly! created! gap! to! close! it! until! new! cellXcell!
contacts! are! established! again.! By! capturing! images! at! the! beginning! (time! point! 0)! and! at!
regular!intervals!during!cell!migration!and!comparison!of!the!images!allow!determining!the!rate!
of! the!migration.! One! of! the!major! disadvantages! of! this! simple!method! is! the! fact! that! it! is!
difficult! to! quantify.! Different! approaches! were! tested! to! quantify! the! migration! rate! of! the!
endothelial! cells:! i)!Counting! the!cells!present! in! the!scratched!area,! ii)!distance!measurement!
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between!the!two!borders,!iii)!and!overgrown!area!calculation!by!pixel!measurement.!In!methods!
ii)! and! iii)! the! size! of! the! scratch! at! time! point! 0! was! set! to! 100%.! For! all! three! methods!
Photoshop! software! (Adobe,! Version! CS5)! was! used.! To! better! distinguish! between! area!













vitro.! Endothelial! cells! are!grown!on!a!matrix! so! that! cell! attachment,!migration,! invasion!and!

























cells!were! stained!with!Calcein!AM!according! to!manufacturer’s! instruction!and!pictures!were!










Ten! candidate! genes! were! sequenced! in! 208 subjects! with! severe! retinal! developmental!
disorders.! All! exonic! and! 50X100bp! flanking! intronic! regions! of! the! candidate! genes! were! biX
directionally!SangerXsequenced.!All!together,!79!new!sequence!variations,!including!23!missense!
mutations! and! two! inXframe! deletions,!were! identified.! The!missense!mutations! and! inXframe!
deletions! might! directly! affect! protein! function.! The! remaining! sequence! variants! are! either!
intronic,! and!might! affect! splicing,! or! they! are! located! in! the! 3’UTR! or! 5’UTR! and! potentially!
affect! either! splicing,! transcript! stability,! or! might! have! an! effect! on! promoter! activity.! An!
overview! of! all! sequence! variations! is! listed! in! table! 35.! A! complete! list! of! all! new! sequence!
variants! in! the! ten! candidate! genes! can! be! found! in! table! 36.! Most! of! theses! sequence!




later.! Some! of! these! sequence! variations! have! been! described! in! the! master! thesis! of! Lea!
Sollfrank,!who!was!involved!in!several!projects!under!my!supervision,!regarding!candidate!gene!
screening!and! functional! characterization.!NINJ1!was!her!main!project,! but! she!also!helped! in!
sequencing! and! analyzing! the! ZNF408! and! PARVA! data,! and! analyzing! sequence! data! from!
TSPAN12,! ILK,! ITGB3! and! SRF0 genes.! In! this! thesis,! a! complete! overview! of! all! sequence!
variations! (including! intronic! and! synonymous! substitutions),! which! were! found! in! the! ten!
candidate! genes! for! retinal! dysplasias,! are! listed! and! described! in! detail! (Tabel! 36).! The!
electropherograms! of! each! new! sequence! variation! can! be! found! in! the! Appendix! B,! of! this!
thesis.!
!
!! Exon! Intron! 5'UTR! 3'UTR!
ATOH7# 2! 0! 0! 1!
NEUROD1# 1! 0! 0! 0!
NINJ1# 1! 0! 2! 0!
ZNF408# 6! 0! 0! 2!
ILK# 5! 4! 0! 0!
ITGB3# 3! 6! 0! 0!
PARVA# 4! 3! 0! 2!
SRF# 4! 0! 0! 0!
MKL1# 10! 5! 4! 1!
MKL2# 6! 6! 1! 0!







ATOH7& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70186& c.121_144del& p.Arg42_Arg48del& Exon&1& &7& &7& &7& Deletion&(in7frame)& homozygous&
70187& c.121_144del& p.Arg42_Arg48del& Exon&1& &7& &7& &7& Deletion&(in7frame)& heterozygous&
70100& c.193A>G& p.Arg65Gly& Exon&1& possibly&damaging&(0.897)& not&tolerated& Class&C45& Missense&mutation& heterozygous&
70102& c.193A>G& p.Arg65Gly& Exon&1& possibly&damaging&(0.897)& not&tolerated& Class&C45& Missense&mutation& heterozygous&
70217& c.193A>G& p.Arg65Gly& Exon&1& possibly&damaging&(0.897)& not&tolerated& Class&C45& Missense&mutation& heterozygous&
70163& c.*35C>T& p.?& 3'UTR& &7& &7& &7& Splicing,&transcript&stability&& heterozygous&
         
NEUROD1& !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70086& c.463_465del& p.Glu155del& Exon&2& &7& &7& &7& Deletion&(in7frame)& heterozygous&
& & & & & & & & &
NINJ1& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70221& c.771727G>A& p.?& 5'UTR& &7& &7& &7& Promotor&region&affected& heterozygous&
70221& c.771714G>A& p.?& 5'UTR& &7& &7& &7& Promotor&region&affected& heterozygous&
70135& c.124G>A& p.Ala42Thr& Exon&2& probably&damaging&(1.000)& not&tolerated& Class&C55& Missense&mutation& heterozygous&
& & & & & & & & &
ZNF408& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70182& c.35A>G& p.Lys12Arg& Exon&1& benign&(0.002)& tolerated&& Class&C0& Missense&mutation& heterozygous&
70205& c.1574G>A& p.Arg525His& Exon&5& benign&(0.081)& tolerated&& Class&C0& Missense&mutation& heterozygous&
70110& c.240C>T& p.=& Exon&2& &7& &7& &7& Synonymous&mutation& heterozygous&
70128& c.1497G>A& p.=& Exon&5& &7& &7& &7& Synonymous&mutation& heterozygous&
70116& c.1755C>T& p.=& Exon&5& &7& &7& &7& Synonymous&mutation& heterozygous&
70139& c.1755C>T& p.=& Exon&5& &7& &7& &7& Synonymous&mutation& heterozygous&
70215& c.*48+95G>C& p.?& 3'UTR& &7& &7& &7& Splicing,&transcript&stability& heterozygous&
70216& c.*48+95G>C& p.?& 3'UTR& &7& &7& &7& Splicing,&transcript&stability& heterozygous&
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ILK& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
25649& c.157T>A& p.Leu53Met& Exon&3& probably&damaging&(1.000)& not&tolerated& Class&C0& Missense&mutation& heterozygous&
70160& c.279C>A& p.=& Exon&4& &7& &7& &7& Synonymous&mutation& heterozygous&
70159& c.631C>T& p.Arg211Cys& Exon&8& possibly&damaging&(0.856)& not&tolerated& Class&C25& Missense&mutation& heterozygous&
70231& c.631C>T& p.Arg211Cys& Exon&8& possibly&damaging&(0.856)& not&tolerated& Class&C25& Missense&mutation& heterozygous&
70147& c.950G>A& p.Arg317Gln& Exon&10& possibly&damaging&(0.615)& tolerated&& Class&C0& Missense&mutation& heterozygous&
70217& c.979737A>C& p.?& Intron&10& &7& &7& &7& Splicing& heterozygous&
70151& c.1079718C>T& p.?& Intron&11& &7& &7& &7& Splicing& heterozygous&
70231& c.1079718C>T& p.?& Intron&11& &7& &7& &7& Splicing& heterozygous&
70246& c.1209+52A>C& p.?& Intron&12& &7& &7& &7& Splicing& heterozygous&
         
ITGB3& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70223& c.72C>T& p.=& Exon&1& &7& &7& &7& Synonymous&mutation& heterozygous&
70211& c.79+15G>A& p.?& Intron&1& &7& &7& &7& Splicing& heterozygous&
70099& c.165+28C>G& p.?& Intron&2& &7& &7& &7& Splicing& heterozygous&
70113& c.847G>A& p.Ala283Thr& Exon&6& probably&damaging&(1.000)& not&tolerated& Class&C55& Missense&mutation& heterozygous&
70128& c.1035+25G>A& p.?& Intron&7& &7& &7& &7& Splicing& heterozygous&
70182& c.1125+31G>A& p.?& Intron&8& &7& &7& &7& Extra&branchpoint& heterozygous&
70217& c.1125+31G>A& p.?& Intron&8& &7& &7& &7& Extra&branchpoint& heterozygous&
70224& c.1530C>T& p.=& Exon&10& &7& &7& &7& Synonymous&mutation& heterozygous&









PARVA& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70110& c.1377154C>T& p.?& Intron&1& &7& &7& &7& new&splice&donor&site& heterozygous&
70198& c.657+18A>G& p.?& Intron&6& &7& &7& &7& Splicing&& heterozygous&
27095& c.762C>T& p.=& Exon&9& &7& &7& &7& Synonymous&mutation& heterozygous&
70151& c.798+15C>T& p.?& Intron&9& &7& &7& &7& Splicing&& heterozygous&
70160& c.828G>A& p.=& Exon&10& &7& &7& &7& Synonymous&mutation& heterozygous&
70228& c.891G>A& p.=& Exon&11& &7& &7& &7& Synonymous&mutation& heterozygous&
70240& c.951G>A&& p.=& Exon&11& &7& &7& &7& New&splice&acceptor&site&& homozygous&
27118& c.*4G>A& p.?& 3'UTR& &7& &7& &7& Transcript&stability& heterozygous&
70108& c.*4G>A& p.?& 3'UTR& &7& &7& &7& Transcript&stability& heterozygous&
& & & & & & & & &
SRF& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
29833& c.147G>T& p.=& Exon&1& &7& &7& &7& Synonymous&mutation& homozygous&
70098& c.534G>A& p.=& Exon&2& &7& &7& &7& Synonymous&mutation& heterozygous&
70234& c.715A>T& p.Thr239Ser& Exon&2& possibly&damaging&(0.853)& tolerated& Class&C0& Missense&mutation& heterozygous&















MKL1& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70223& c.7496C>T& p.?& 5'UTR,&Exon&1& 7& 7& 7& Translation&regulation& heterozygous&
70092& c.7333A>G& p.?& 5'UTR,&Exon&2& 7& 7& 7& Translation&regulation& heterozygous&
70245& c.7260T>C& p.?& 5'UTR,&Exon&3& 7& 7& 7& Translation&regulation& heterozygous&
70176& c.7260T>C& p.?& 5'UTR,&Exon&3& 7& 7& 7& Translation&regulation& heterozygous&
70213& c.301+12C>G& p.?& Intron&7& 7& 7& 7& Splicing& heterozygous&
70229& c.4787125C>T& p.?& Intron&8& 7& 7& 7& Splicing& heterozygous&
70196& c.627+79G>C& p.?& Intron&9& 7& 7& 7& Splicing& heterozygous&
70213& c.627+113C>T& p.?& Intron&9& 7& 7& 7& Splicing& heterozygous&
70136& c.726C>T& p.=& Exon&10& 7& 7& 7& Synonymous&mutation& heterozygous&
70239& c.753G>C& p.=& Exon&10& 7& 7& 7& Synonymous&mutation& heterozygous&
70246& c.1408T>C& p.Ser470Pro& Exon&12& probably&damaging&(0.998)& not&tolerated& Class&C0& Missense&mutation& heterozygous&
70214& c.1695C>A& p.=& Exon&12& 7& 7& 7& Synonymous&mutation& heterozygous&
70116& c.1699G>A& p.Ala567Thr& Exon&12& benign&(0.016)& tolerated& Class&C0& Missense&mutation& heterozygous&
70148& c.1699G>A& p.Ala567Thr& Exon&12& benign&(0.016)& tolerated& Class&C0& Missense&mutation& homozygous&
70135& c.1705G>A& p.Ala569Thr& Exon&12& benign&(0.001)& tolerated& Class&C0& Missense&mutation&(rs144888766)& heterozygous&
70147& c.1720C>T& p.Pro574Ser& Exon&12& benign&(0.000)& tolerated& Class&C0& Missense&mutation& heterozygous&
70111& c.1723G>A& p.Val575Met& Exon&12& probably&damaging&(0.996)& tolerated& Class&C0& Missense&mutation& heterozygous&
70190& c.1909G>A& p.Ala637Thr& Exon&12& benign&(0.002)& not&tolerated& Class&C55& Missense&mutation& heterozygous&
70226& c.1909G>A& p.Ala637Thr& Exon&12& benign&(0.002)& not&tolerated& Class&C55& Missense&mutation& heterozygous&
70243& c.2003T>C& p.Val668Ala& Exon&12& possibly&damaging&(0.712)& not&tolerated& Class&C0& Missense&mutation& heterozygous&









MKL2& !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70225& c.76371G>C& p.?& Intron&2& 7& 7& 7& Splicing& heterozygous&
70221& c.221734A>G& p.?& Intron&4& 7& 7& 7& Splicing& heterozygous&
70206& c.300G>A& p.=& Exon&6& 7& 7& 7& Synonymous&mutation& heterozygous&
70243& c.761C>G& p.Pro254Arg& Exon&9& Benign&(0.002)& tolerated& Class&C0& Missense&mutation& heterozygous&
70227& c.983G>A& p.Arg328His& Exon&10& probably&damaging&(1.000)& not&tolerated& Class&C25& Missense&mutation& heterozygous&
70244& c.1317C>T& p.=& Exon&12& 7& 7& 7& Synonymous&mutation& heterozygous&
70189& c.2097+94A>G& p.?& Intron&12& 7& 7& 7& Splicing& heterozygous&
70189& c.2098730A>C& p.?& Intron&12& 7& 7& 7& Splicing& heterozygous&
70189& c.2253+25G>A& p.?& Intron&13& 7& 7& 7& Splicing& heterozygous&
70189& c.2253+51C>T& p.?& Intron&13& 7& 7& 7& Splicing& heterozygous&
70189& c.2449G>A& p.Val817Ile& Exon&15& Benign&(0.048)& tolerated& Class&C0& Missense&mutation& heterozygous&
27116& c.2548C>A& p.Pro850Thr& Exon&15& Benign&(0.084)& tolerated& Class&C0& Missense&mutation& heterozygous&





In% ATOH7,% one% in*frame% deletion% (c.121_144del,% p.Arg42_Arg48del),% one% previously% reported%
amino% acid% substitution% (c.193A>G,% p.Arg65Gly,% rs111699024),% and% one% variation% in% the% 3’UTR%
(c.*35C>T,%p.?)%were% found.% For% the% in*frame%deletion% I% refer% to% the%manuscript%enclosed%here%
after.%The%known%SNP%was%found%three%times,%always%heterozygous.%The%variation% in%the%3’UTR%
was%found%only%once%and%might%influence%transcript%stability.%








The% E*boxes% between% the%mouse% and%human% gene% are% conserved.% To% investigate%whether% the%
human% ATOH7% is% capable% to% regulate%Ndp% transcription,% TaqMan% analysis% was% used.% Relative%
transcript% levels% of%Ndp% in%mouse% retinas%were% quantified% after% electroporation% of% the% human%
wild% type% ATOH7% construct% and% compared% to% mouse% retinas% which% were% not% electroporated.%





wild% type% ATOH7% electroporated% and% unelectroporated% mouse% retinae% were% observed% in% our%
experiment%(data%not%shown).%
%
In% addition% to% the% ex( vivo(mouse% experiment,% RT*PCR% on% HEK293T% cells% transfected%with%wild%
type% and%mutant% ATOH7%was% performed.% In% this% in( vitro% experiment% transcript% levels% of%NDP,%
ATOH7,%and%18S%as%an%internal%control%were%analyzed.%No%differences%in%transcript%levels%of%NDP%
and% ATOH7% between% samples% transfected% with% either% wild% type% or% mutant% ATOH7% were%
observed.%
%
The%deletion% in% the%basic%DNA%binding%domain%of%ATOH7%very% likely% affects% the%binding%of% the%
mutant%protein%to%DNA.%To%investigate%the%interaction%of%ATOH7%and%DNA,%a%fluorescence*based%
electromobility% shift% assay% (EMSA)% was% performed.% The% ATOH7% wt% construct% was% not% able% to%
induce% a% band% shift% in% this% assay.% This%might% be% due% to% the% fact% that%ATOH7%needs% its% binding%





the% luciferase%gene% (pE7*BA*PGV).%As%a%negative%control,% the%same%vector%without% the%E*boxes%



































the# earliest# expressed# transcriptional# activators# of# neurogenesis# in# eye# development# and#
initiates#retinal#ganglion#cell#(RGC)#fate#determination#in#vertebrates.#Depletion#of#Atoh7#in#mice#
results# in# the# loss# of# RGCs,# abnormal# retinal# vascular# development# and# persistence# of# the#
hyaloid#vasculature.#A#similar#phenotype,#with#respect#to#abnormal#vascular#development#in#the#
eye,#can#be#observed# in#Norrin#knockout#(Ndpy/[)#mice,#a#model#for#Norrie#disease.# In#humans,#
loss# of# RGCs# often# leads# to# retinal# detachment# and# blindness.# Retinal# vascular# defects# and#
persistence# of# hyaloid# vessels# occur# in# several# human# congenital# eye# diseases# including#
exudative#vitreoretinopathy#(EVR),#Norrie#disease#(ND),#retinopathy#of#prematurity#(ROP),#Coat’s#
disease#and#persistent#hyperplastic#primary#vitreous#(PHPV).#
By# direct# sequencing# of#ATOH7# we# found# a# homozygous# deletion# of# eight# amino# acids# in# the#
basic# domain# of# ATOH7# in# a# patient# with# severe# bilateral# retinal# dysplasia# similar# to# ND.#
Functional# analysis#of# the#mutant#ATOH7# revealed# that# the#protein# is#mislocalized#and# rapidly#















cone# photorezeptor# cells# develop# in# an# overlapping# phase,# followed# by# rod# photoreceptors,#
bipolar#and#müller# glial# cells,#which#are#established# last# [4]–# [6].# To# form# the#highly#organized#
laminar#structure#of#these#different#cell#types,#retinal#progenitor#cells#have#to#differentiate#and#
migrate# in#a#distinct#manner#which# is#guided#by#both# intrinsic#and#extrinsic# factors# [7].#During#
retinogenesis,#bHLH#transcription#factors#like#ATOH7#(also#known#as#MATH5#or#ATH5),#MASH1,#
MATH3,# NGN2,# and# NEUROD1# are# activated# in# a# subpopulation# of# progenitor# cells# and#
determine# cell# fate# decisions# of# retinal# progenitor# cells# [8]–# [13].# Atoh7) is# one# of# the# best#
characterized# bHLH# transcription# factor# genes# involved# in# retinal# development# in# different#
species# and# is# thought# to# initiate# neurogenesis# in# vertebrate# and# invertebrate# eyes# [9],# [14]–#
[19].#The#human#ATOH7#is#encoded#by#a#single#exon#and#consists#of#152#amino#acids#[20].#Amino#
acid#residues#41#–#52#form#the#basic#domain,#which#is#important#for#DNA[binding.#Residues#53#–#
93# form# the# helix[loop[helix#motif# which# is# important# for# hetero[# or# homo[dimerization# [21],#
[22].#
The# expression# pattern# of# Atoh7) in# retinal# progenitor# cells# of#Mus) musculus# (Mouse# atonal#
homolog# 7,# Atoh7# also# known# as) Math5),# Xenopus) laevis# (Xenopus# laevis# atonal# homolog# 7,#







nerve.# Axons# of# RGCs# assemble# the# optic# nerve# and# dispatch# signals# from# the# retina# to# the#
lateral#geniculate#nucleus#from#where#information#is#processed#to#the#visual#cortex.#In#addition,#
a#subset#of#RGC#axons#projects#directly#to#the#suprachiasmatic#nucleus,#which#controls#circadian#




[31].# Atoh7# overexpression# experiments# in# chicken# and# frog# eyes# lead# to# a# promoted# RGC#
neurogenesis# and# photoreceptor# abundance# [16],# [19],# [32],# [33],# and# ectopic# expression# of#
atonal#during#Drosophila#eye#development#induces#extra#R8#cells#[34],#[35].#Thus,#several#lines#of#
evidence,# including# expression,# depletion,# and# overexpression# of# Atoh7# in# different# species,#
suggest#a# role#of# this# transcription# factor#during# retinal#development# in#vertebrates#as#well#as#
invertebrates.#Recently,#a#deletion#of#a#remote#enhancer#in#a#large#consanguineous#family#with#
nonsyndromic# congenital# retinal# nonattachment# (NCRNA,#MIM# ## 221900)# has# been# described#
and# the# authors# suggested# for# the# first# time# that# ATOH7# is# implicated# in# severe# human# eye#
diseases# [36].# The# ocular# symptoms# of# the# patients# are# reminiscent# of# the# ocular# phenotype#
seen#in#some#Norrie#disease#patients.#Norrie#disease#is#a#severe#X[linked#recessive#disorder#with#
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retinal# dysplasia# and# shows# highly# variable# syndromic# symptoms# including# progressive#
sensorineural# hearing# loss# and# cognitive# impairment# [37]–# [42].# Therefore# we# screened# for#
mutations#in#ATOH7)in#more#than#200#human#patients#with#the#clinical#diagnoses#EVR,#PHPV,#or#
ND#which#were#negative#for#disease[causing#sequence#alterations#in#one#of#the#known#genes.##
Here# we# report# a# novel# mutation# in# ATOH7) and# describe# functional# consequences# of# this#













childhood,#adolescence#or# later# in# life.#Six#years#after#the# initial#clinical#examination# it#was#not#
possible#to#perform#additional#clinical#examinations.#
The#patient#is#homozygous#for#an#in#frame#deletion#in#the#basic#domain#of#ATOH7#(c.121_144del,#
p.Arg41_Arg48del).# His# unaffected# mother# is# heterozygous# for# the# same# deletion# and# we#






different# ATOH7# orthologous# genes# with# a# multiple# sequence# alignment# (MSA)# by# using#
ClustalW2# (Figure# II,# A).# The# deletion# described# herein# encompasses# eight# highly# conserved#
amino#acids#of#the#basic,#DNA[binding#domain#of#ATOH7.#To#illustrate#the#binding#of#ATOH7#to#







visualized# the# protein# localization# by# immunofluorescence#microscopy# (Figure# III,# A).# The#wild#
type#protein#was# found#predominately# in# the#nucleus,#while# the#mutant#ATOH7#was#observed#
significantly# less# frequent# in# nuclei# (Figure# III,# B).# We# repeated# this# experiment# in# HEK293T#
(Human#embryonic#kidney)#cells#and#obtained#the#same#result#(data#not#shown).#In#addition#to#
immunofluorescence# stainings,# we# performed# a# fractionation# of# cytoplasmic# and# nuclear#
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proteins# of# transfected# HEK293T# cells.# Western# blot# analysis# of# whole# cell,# nuclear# and#
cytoplasmic# fractions# confirmed# the# immunocytochemical# data# (Figure# IV).# In# particular,#
Western#blot#analysis#revealed#that#mutant#ATOH7#in#general#is#less#abundant#compared#to#the#
wild#type#construct.#Only#very#little#amounts#of#mutant#ATOH7#protein#were#detected#in#nuclear#
fractions.# But# also# in# whole# cell# and# cytoplasmic# fractions# less# mutant# ATOH7# was# present#
compared# to# wild# type# ATOH7.# The# relative# nuclear# abundance# of# mutant# ATOH7# was#
significantly#lower#compared#to#wild#type#ATOH7#(Figure#IV,#B).#In#contrast,#the#wild#type#ATOH7#
was#more#abundant#in#the#nucleus#compared#to#the#cytoplasm.#Since#the#wild#type#ATOH7#was#
more# abundant# in# the# whole# cell# lysate# than# the# mutant# protein,# we# examined# transfection#
efficiencies# between# the# constructs.# We# repeated# the# transfection# of# wild# type# and# mutant#
ATOH7# plasmid#DNAs# and# also# cotransfected#GFP.# Cotransfected# and# fractionated# cell# lysates#
were# subjected# to# immunoblotting# using# anti[V5[tag# and# anti[GFP# antibodies.# Western# blot#
analysis#of#V5[tagged#ATOH7#always# revealed# the# same#pattern# (Figure# IV,#A).#GFP#expression#
levels# were# comparable# when# cotransfected# together# with# different# ATOH7# expression#
constructs,# suggesting# equal# transfection# efficencies.# As# a# loading# control# for# whole# cell# and#
cytoplasmic#fractions#β[tubulin#was#used,#for#nuclear#fractions#Histone#H3.#Taken#together,#less#
mutant#ATOH7#protein#was# found# in#whole# cell# lysate#and# its# relative#nuclear# abundance#was#
significantly# lower# compared# to# wilde# type# ATOH7# protein.# These# results# suggest# that# the#












to# the# total# amount#of#ATOH7,# the# relative#nuclear# abundance#of# the#NLS_del#ATOH7#protein#
could#be#increased#to#a#similar#level#as#it#has#been#observed#with#the#wild#type#ATOH7#(Figure#IV,#
B).# This# experiment# suggests# that# the# nuclear# localization# of# ATOH7# has# a# protective# effect#






we# treated# HEK293T# cells# 24# hours# after# transfection# with# the# different# ATOH7# expression#
constructs#by#using#the#proteasome#inhibitor#MG[132#for#0,#1,#2,#4,#and#8#hours,#or#DMSO#as#a#
vehicle# control.# Subsequently,# cell# lysates# were# harvested# and# subjected# to# immunoblotting#




localization# of# ATOH7# prevents# proteasomal# degradation.# In# addition,# we# used# a# second#
proteasome#inhibitor#(epoxomicin)#with#the#same#results#(Figure#V,#B).#However,#ATOH7#protein#
accumulation#could#not#be#achieved#with#an#inhibitor#of#lysosomal#protein#degradation#(NH4Cl,#




To# further# investigate# the# mechanism# of# ATOH7# degradation,# we# examined# the# stability# of#
ATOH7# in#HEK293T#cells.#We# incubated#transfected#HEK293T#cells# for#4#hours#with#MG[132#to#
stabilize#ATOH7#and#then#added#the#protein#synthesis#inhibitor#cycloheximide#(CHX).#Cells#were#
lysed# 0,# 1,# 2,# 4,# and# 8# hours# after# incubation# with# CHX.# The# decay# of# ATOH7# over# time# was#
assessed#by#Western#blot#analyses#(Figure#VI).#This#experiment#revealed#that#the#half[life#(t½)#of#
wild# type#ATOH7# is#~#4#hours,#wherease# the#mutant#ATOH7#had#a# reduced#half[life# (t½)#of#~#2#
hours.# Therefore#we# show#an# increased# turnover# rate#of# the#mutant#ATOH7# compared# to# the#






To# see#whether#mutant#ATOH7# is# present# in#higher# amounts# in# the#nucleus# after# stabilization#
with#the#proteasome#inhibitor,#we#fractionated#transfected#HEK293T#cells#after#4#hours#of#MG[
132# treatment# and# examined# the# whole# cell,# nuclear# and# cytoplasmic# fractions# by#
immunoblotting#(Figure#VII).#This#experiment#revelad#that#a#larger#amount#of#mutant#ATOH7#is#
still# localized# in# the# cytoplasm,# even# after# protein# stabilization.# This# further# supports# the#







nucleotides# (Figure# I).# We# suggest# a# microhomology[mediated# end# joining# mechanism# which#
gives#rise#to#the#in#frame#deletion.#The#deletion#comprises#eight#highly#conserved#amino#acids#of#









Crystallographic# and# functional# data# for# E47# and# other# bHLH#proteins# indicate# that# the# highly#
conserved#basic#domains#play#an# important#role# for# interaction#with#DNA#[21],# [22],# [46],# [47].#
Further,# it# has# been# shown# that# p.Asn46His# mutant# ATOH7# is# neither# able# to# bind# DNA# nor#
initiate#transcription#of#a#specific#reporter#[48].#Since#almost#the#entire#basic#domain#is#deleted#
in# the#mutant#ATOH7#protein,# it# can#be#expected#that# the#mutant#protein,#which# is#present# in#




cis# regulatory# element,# 20# kb# upstream# of# ATOH7,# as# disease# causing# in# humans# with#
nonsyndromic# congenital# retinal# nonattachment# [36].# The# authors# suggest# that# this# deletion#
reduces# or# entirely# silences# ATOH7# expression.# Our# findings# are# also# consistent# with# recent#
observations,# which# provide# functional# evidence# for# the# first# time# that# a# missense# mutation#
(p.Asn46His)# in# the# DNA[binding# domain# of# ATOH7# is# implicated# in# PHPV# [48].# The#mutation#
p.Asn46His# affects# DNA[binding# and# transcriptional# activation# of# target# gene# expression.# We#
now# present# functional# evidence# that# a# mislocalization# and# increased# turnover# of# the#
p.Arg41_Arg48del#ATOH7#causes#severe#retinal#dysplasia.#The#deletion#in#our#patient#as#well#as#
the# two# previously# reported# cases# most# likely# result# in# ATOH7# deficiency# in# the# nucleus# and#
therefore#leads#to#similar#eye#phenotypes#in#humans.#
The# striking# similarities# between# Atoh7=/=# and# Ndpy/=# mice# as# well# as# human# patients# with#
mutations# in# the# respective# genes# might# result# from# the# close# interaction# between# the#
development# of# RGCs# and# the# retinal# vasculature.# Atoh7# is# crucial# for# RGC# development# and#
when#this# is#disrupted,#vascular#defects#can#be#observed#within#the#eye.#Norrin,#the#NDP#gene#
product# on# the# other# hand,# is# important# for# the# development# of# the# retinal# vasculature,# and#
when# this# process# fails,# RGCs# start# to# degenarate,# at# least# in# the# mouse# model# [49]–# [51].#
Mutations#in#these#two#genes#(ATOH7#and#NDP)# lead#to#similar#eye#phenotypes#but#whether#a#
direct# molecular# interaction# of# the# respective# proteins# exist,# or# whether# two# distinct#
mechanisms#or#signaling#cascades#lead#to#similar#phenotypes#remains#to#be#answered.#
Furthermore,#several#association#studies#linked#ATOH7#to#human#optic#disc#size,#which#is#directly#
related# to# the#number#of# RGCs# [52]–# [54],# but# also#open[angle# glaucoma# [55],# [56].# In# one#of#
these#studies,#two#missense#mutations#in#ATOH7#have#been#described#(p.Arg65Gly,#p.Ala47Thr)#
in# patients# with# optic# nerve# hypoplasia# [52].# Recently,# in# a# combinatory# approach# of# auto[
zygosity# mapping# and# next# generation# sequencing,# two# homozygous# mutations# (p.Glu49Val,#
p.Pro18ArgfsX69)#in#two#consanguineous#families#diagnosed#with#multiple#ocular#developmental#
defects#were#identified#[57].#









Written# informed# consent# was# obtained# from# all# patients# involved# in# this# study.# The#
Massachusetts# General# Hospital# Institutional# Review# Board# approved# consent# procedure.# The#













°C# (2# min),# and# a# final# extension# at# 72# °C# for# 10#min.# For# the# second# fragment,# HotFire# Taq#
polymerase# (Solis# BioDyne,# Tartu,# Estonia)# was# used.# Initial# incubation# at# 95# °C# for# 15# min,#
followed#by#35#cycles#of#95#°C#(1#min),#60#°C#(1#min),#72#°C#(2#min),#and#a#final#extension#at#72#°C#
for#10#min.#Primers#were#as#follows:##












del# for# (5’[GGGATGAAGTCCTGCAAGC[3’)# and# as# reverse# primer# ATOH7_Ex1# del# rev# (5’[




For#multiple# sequence# alignment# (MSA),# the# protein# sequences# of#ATOH7#of# different# species#
were#downloaded#from#NCBI#(http://www.ncbi.nlm.nih.gov/protein)#and#the#alignments#of#the#
bHLH# domain# were# calculated# using# ClustalW2# (http://www.ebi.ac.uk/clustalw2).# Sequence#
alignment# was# carried# out# with# the# following# reference# sequences:# NP_660161.1# (human),#
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the#patient.# The#amplified# fragment#was# cloned# in# the#expression# vector#pcDNA3.1/nV5#using#
the#Gateway#cloning#system#(Invitrogen,#Basel,#Switzerland).#This#vector#has#a#CMV#promoter#to#
express#N[terminal# V5# fusion# proteins.#We# generated# four# different# constructs,# including#wild#
type#ATOH7#(ATOH7#wt),#mutant#(p.Arg41_Arg48del)#ATOH7#(ATOH7#del),#wild#type#ATOH7#with#
an#artificial#NLS#(ATOH7#NLS_wt),#and#mutant#(p.Arg41_Arg48del)#ATOH7#with#an#artificial#NLS#













Aldrich,# Buchs,# Switzerland)# in# 12# well# plates# at# a# density# of# 5*104# cells# /# well.# Cells# were#
transiently# transfected#with# 1# µg#DNA#per#well# of# the# respective# expression# vectors# using# PEI#
(Sigma[Aldrich,# Buchs,# Switzerland)# according# to# manufacturer’s# instructions.# 24# hours# after#
transfection,# cells# were# fixed# with# 4%# paraformaldehyde# for# 10# min,# washed# with# PBS# and#
permeabilized#with#0.1%#Triton#X[100#for#15#min#to#detect#intracellular#V5[tagged#proteins.#Non[
specific#binding#was#blocked#with#1%#BSA#in#PBS#for#30#min.#Immunocytochemistry#was#carried#
out#with#primary# antibody# anti[V5# (Sigma[Aldrich,# 1:100)# for# 1#hour.# Cells#were#washed# three#
times#with# PBS.# As# a# secondary# antibody# anti[Alexa# Fluor# 488# (green)# (Invitrogen,# 1:200)#was#
used#for#40#min.#Cells#were#washed#in#PBS#and#mounted#in#DAPI#containing#mounting#medium#
(Vectashield®,#Vector#Laboratories,#Burlingame,#CA,#USA).#Immunocytochemistry#was#performed#
at# room# temperature.# Immunostaining# was# visualized# by# fluorescence# microscopy# using# an#
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Axioplan#microscope#(Zeiss,#Hombrechtikon,#Switzerland).#Quantitative#studies#were#carried#out#































quantified# using# ImageJ# software# and#normalized# on#β[tubulin# loading# control,# all# time#points#
were# compared# with# time# 0# and# expressed# as# a# percentage# thereof.# The# degradation# rate# is#




Protein# extracts# were# separated# on# 12%# SDS[polyacrylamide# gels# and# transferred# onto#
polyvinylidene# difluoride# (PVDF)# membranes# (Roche# Diagnostics,# Rotkreuz,# Switzerland),# and#
probed#with#an#anti[V5#antibody# (1:1000,# Sigma[Aldrich,#Buchs,# Switzerland).# To#normalize#on#
nuclear#and#cytoplasmic#protein#amounts,#blots#were#stripped#and#incubated#with#a#polyclonal#
rabbit# antibody# against# Histone# H3# (1:1000,# Abcam,# Cambridge,# MA,# USA),# β[tubulin# (1:500,#
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Abcam,# Cambridge,# MA,# USA)# respectively.# As# a# transfection# efficiency# control,# GFP# was#
cotransfected#and#blots#were# incubated#with#GFP#antibody# (1:2000,# Santa#Cruz#Biotechnology#
Inc.,# Heidelberg,# Germany).# As# a# secondary# antibody# anti[rabbit# HRP# (1:2000,# GE# Healthcare,#
Glattbrugg,#Switzerland)#or#anti[mouse#HRP#(Dianova#GmbH,#Hamburg,#Germany)#were#used.#All#
blots#were#visualized#by#enhanced#chemiluminescence#(ECL,#Perkin#Elmer,#Waltham,#MA,#USA).#






















































































































































































































(A)# Pedigree# and# genetic# analysis# of# the# patient# and# his# mother.# Deletion[flanking# primers#
amplify#a#186#bp# fragment# in# the#control# (C).# The#mother# (I.2)# is#heterozygous# for# the#normal#
and# the#deleted#allele#while#her# son# (II.1)#only# shows# the#deleted#allele.#DNA# from# the# father#
was#not#available#for#genetic#testing.#(M=#size#marker)#
(B)# Sequence# profiles# from# PCR# products# representing# the# wild# type# (wt)# and# mutant#
(c.121_144del)# alleles#of#ATOH7.# The#deletion#of#24#nucleotides# is# flanked#on#either# side#by#a#
stretch#of#6#completely#identical#nucleotides.#This#region#of#microhomology#is#indicated#in#grey.#





(A)# Multiple# sequence# alignment# of# the# bHLH# domain# of# ATOH7# protein# sequences# from#
different#species.#The#deletion#of#eight#amino#acids#is#highlighted#in#blue.#All#eight#amino#acids#
which# are# deleted# in# the# patient# are# highly# conserved# between# all# the# investigated# species.#
Structural# motifs# of# the# bHLH# domain# of# human# ATOH7# are# indicated# above# the# amino# acid#
sequence.#The#deletion#affects#the#basic,#DNA[binding#domain#of#ATOH7.#
(B)# 3D#model# of# the# bHLH# domain# of# human#wild# type# ATOH7# (in# green)# dimerized#with# the#
transcription#factor#E47#(in#grey)#and#bound#to#double[stranded#DNA.#Amino#acid#residues#of#the#









tagged#ATOH7#was#predominantly# localized# in#the#nucleus,#whereas#nuclear# localization#of# the#










(A)#Western# blot# analysis# of#whole# cell,# nuclear# and# cytoplasmic# fractions# from#HEK293T# cells#
transfected#either#with#the#wild#type#or#mutant#expression#constructs#of#ATOH7#with#or#without#




artificial#NLS# to# the#mutant#ATOH7,#nuclear# localization#of# the#protein# is# rescued.#anti[Histone#




one[way# ANOVA# of# relative# nuclear# abundance# yielded# a# highly# significant#main# effect# of# the#
genotype# [F(3,8)=# 32.167,# P<# 0.0001].# Subsequent# post[hoc# analyses# verified# the# significant#
difference# between# ATOH7# wt# and# ATOH7# del# (***,# P<0.0001)# and# ATOH7# del# and# ATOH7#







transfection# MG[132# was# added# for# indicated# times.# Cells# were# harvested# and# subjected# to#











(A)# HEK293T# cells#were# cotransfected#with# the# indicated# ATOH7# construct# and#GFP.# 24# hours#
after# transfection# cells#were# treated#with#MG[132# for# 4# hours# to# stabilize#ATOH7# followed#by#
CHX# (Cycloheximide)# treatment# for# the# indicated# times.#Cells#were#harvested#and#analyzed#by#
Western#blot#using#antibodies#as#indicated.#(GFP:#green#fluorescence#protein).##







(A)# HEK293T# cells#were# cotransfected#with# the# indicated# ATOH7# construct# and#GFP.# 24# hours#
after# transfection# cells#were# treated#with#MG[132# to# stabilize#ATOH7#or# (B)#with#DMSO# for# 4#
hours.# Cells# were# harvested# and# fractionated,# whole# cell,# nuclear,# and# cytoplasmic# fractions#
were#analyzed#by#Western#blot#using#antibodies#as#indicated.#(GFP:#green#fluorescence#protein).#
#
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One# in[frame# deletion# (c.463_465del,# p.Glu155del)# was# found# in# a# female# cousin# of# a# Norrie#
male# patient.# It# is# an# in[frame# deletion# of# three# nucleotides,# which# encode# for# a# highly#
conserved#amino#acid.#The#deleted#amino#acid#is#located#in#a#basic#helix[loop[helix#dimerization#
region#of#NEUROD1.#The#mutation#might#affect#binding#to#its#dimerization#partners#(NEUROD1,#




One#missens#mutation# and# two# sequence# alterations# in# the# 5’UTR#were# found.# The#missense#
mutation# leads# to# an# exchange# from# alanine# to# threonine# at# position# 42.# The# physiological#
difference#of#these#two#amino#acids#is#small,#but#the#alanine#is#very#well#conserved#throughout#
evolution#(Appendix#B).#All#in)silico#prediction#programs#predicts#this#exchange#to#be#deleterious.#





wild# type# NINJ1# isoform# in# a#Wnt# reporter# luciferase# assay.# She# did# not# see# any# differences#
between#wt#and#mutant#NINJ1#(Master#thesis#Lea#Sollfrank#2011).#NINJ1#is#known#to#be#located#
in#the#cell#membrane#and#function#as#a#cell#adhesions#molecule#and#is#involved#in#macrophage#
induced#programmed#cell# death#during#early#ocular#development# (Araki# et# al.# 1997,# Lee#et# al.#
2009).#Therefore,#we# transfected#COS[7#and#HEK293T#cells#with# the#mutant#and# the#wild# type#




the# cell# membrane,# whereas# only# 12.5%# of# the# mutant# NINJ1# transfected# cells# show# a#
membrane# staining# (Figure# 14).# The# mutant# isoform# aggregated# next# to# the# nucleus# and# we#
speculated# it#might#be# trapped# in# the#endoplasmic# reticulum.#Unfortunately#an#ER# co[staining#
did# not# reveal# a# co[localization# of#mutant#NINJ1# and# ER#marker.#NINJ1# is# involved# in# cell[cell#
interaction#and#adhesion#of#macrophages#and#the#mutation#(p.Ala42Thr)#lies#in#the#extracellular#
domain,# behind# the# homophilic# adhesion# domain# which# consists# of# the# proline# and# the#
asparagine#at#position#26#and#37#respectively.#I#tried#to#transfect#BV[2#cells#(a#gift#from#Prof.#Dr.#
















We# screened# ZNF408# in# our# patient# cohort,# in# the# framework# of# a# collaboration# with# Frans#
Cremers#at#the#University#of#Nijmegen#(Holland)#to#investigate#the#role#of#ZNF408#in#autosomal#
dominant# FEVR.#We# could# show# that#ZNF408# is# a# novel# gene# underlying# autosomal# dominant#
FEVR.#The#manuscript#regarding#this#project#has#recently#been#submitted#to#Proceedings#of#the#
National# Academy# of# Sciences# of# the# United# States# of# America.# We# found# two# missense#
mutations,#four#synonymous#mutations,#and#two#sequence#alterations#in#the#3’UTR.#The#amino#
acids#at#position#12#and#525#are#only#weakly#conserved#and# the#substituted# residues# found# in#
our#patients#have#only#small#physicochemical#differences#to#the#naturally#occurring#amino#acids.#
Therefore,# these#missense#mutations# are# predicted# to# be# not# deleterious# by# all# three# in) silico#
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We#screend# ILK,# ITGB3#and#PARVA# in#our#patients,# in#a#collaborative#effort#regarding#a#project#
together#with#Prof.#Ralf#Adams#at#the#Max[Planck#Institute#for#Molecular#Biomedicine##(Münster,#





In# ILK# we# found# three# different# missense# mutations# one# of# which# was# found# twice# in# two#
unrelated# patients.# Further,#we# found# one# synonymous#mutation,# and# four# intronic# sequence#
alterations.#All#three#missense#mutations#affect#a#highly#conserved#amino#acid.#In#one#mutation#
(p.Arg211Cys)#the#physicochemical#difference#between#the#mutated#and#the#normally#occurring#
amino#acid# is# large.# In#one#case# (70159),#where#we#found#the#p.Arg211Cys#mutation,#we#were#
able#to#collect#paternal#DNA.#The#father#of#this#female#patient#is#homozygous#for#the#C#allel#and#
the# mother# is# heterozygous# C/T# as# the# affected# daughter# (Figure# 15).# For# the# other# two#
mutations# (p.Leu53Met,# p.Arg317Gln)# the# physicochemical# difference# is# small.# p.Arg211Cys# is#
predicted# to# be# deleterious# by# all# three# prediction# programs,# p.Leu53Met# is# predicted# to# be#
deleterious#by#two#prediction#programs#and#p.Arg317Gln# is#predicted#to#be#not#deleterious#by#
all# prediction# programs. The# mutation# at# position# 53# affects# the# ankyrin# domain,# which# is#
responsible#for#protein[protein# interaction#and# localizes# ILK#to#focal#adhesions,#and# induces#an#
alternative# start# codon# at# this# position.# The# mutation# at# position# 211# lies# within# the# PH[like#
domain# of# the# ILK# protein,# which# has# been# shown# to# bind# phosphatidylinositol[3,4,5[
trisphosphate#(PIP3).#The#mutation#at#position#317#affects#the#catalytic#kinase#domain#of#ILK.#ILK#















(especially# the# p.Leu53Met).# Further,# we# suggested# that# they# might# influence# cytoskeleton#
structure,#especially#for#the#p.Arg317Gln#variant.#Therefore,#we#did#an#immunocytochemical#co[
staining#for#V5[tagged#ILK#and#phalloidin#(F[actin#marker)#in#HEK293T#and#COS[7#cells#(Figure#16).#
Wild# type,# p.Arg211Cys,# and# p.Arg317Gln# were# localized# in# the# cytoplasm# and# no# clear#
localization# at# focal# adhesions# could# be# shown.# p.Leu53Met#was# not# detectable# in# all# in# four#


























regulate# endogenous# ILK# in# HEK293T# using# siRNA# (Life# Technologies,# Zug,# Switzerland),# and#









on#Wnt# reporter# activity# (data# not# shown).#We# then# tested#whether# the# siRNA# knockdown# is#
efficient# and#performed#a#RT[PCR# for# human# ILK#on#HEK293T# cells# (Figure#19).#No#differences#
were#observed#between# ILK# specific# siRNA# (siRNA24#and# siRNA43)#and# siRNA#negative# control#
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One#missense#mutation# (p.Ala283Thr),# two# synonymous#mutations# and# six# intronic# sequence#
alterations# were# found.# The# amino# acid# at# position# 283# is# very# well# conserved# throughout#
evolution# and# the# exchange# to# a# threonine# is# predicted# to# be# deleterious# by# all# prediction#





Four# synonymous# mutations,# three# intronic# mutations# and# two# variants# in# the# 3’UTR# were#







One# missense# mutation# (p.Thr239Ser)# and# three# synonymous# mutations# were# detected.# The#
threonine# at# position# 239# is# highly# conserved# throughout# evolution# but# the# physicochemical#





Seven# missense# mutations# were# detected.# Three# mutations# (p.Ala567Thr,# p.Ala569Thr,#
p.Pro574Ser)# were# predicted# to# be# not# deleterious# by# all# three# prediction# programs.# The#
prediction# of# the# remaining# mutations# revealed# contradictory# results# between# the# three#
programs.# Three#missense#mutations#p.Ser470Pro,# p.Ala637Thr# and#p.Val668Ala# are#predicted#
to#be#deleterious#by#two#prediction#programs,#whereas#one#program#predicted#these#mutations#
as#not#deleterious.#One#mutation#(p.Val575Met)#is#predicted#to#be#deleterious#by#one#prediction#
program,#whereas# the#other# two#predict# this#mutation#not# to# be#deleterious.#Only# the# amino#
acid# at# position# 470# is# highly# conserved,# all# others# are# not# 100%# conserved.# Three#nucleotide#
variations# were# found# in# the# 5’UTR# and# might# influence# the# regulation# of# transcription# or#
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Five# missense# mutations# and# two# synonymous# mutations# were# detected.# The# mutations# at#





Beside# the# candidate# genes,# already# known# disease# causing# genes#were# sequenced.#NDP# was#
sequenced#in#a#male#patient#with#suspicion#on#Norrie#disease.#TSPAN12#was#sequenced#in#all#the#




# Exon+ Intron+ 3'UTR+
NDP, 1# 0# 0#





The# index#patient,#a#male# infant#was#born#on#schedule# (16th# July#1990)#after#an# inconspicuous#
pregnancy#with# normal# birth#weight.# Postnatally,# a# retinopathy#was# diagnosed# and# the# index#
patient# was# referred# to# a# retinal# specialist# at# the# age# of# eleven#months.# In# the# right# eye,# an#
intraocular# pressure# of# 25mm#Hg,# a# cloudy# cornea,# vascular# papillary#membrane# covering# the#
papillary# area,# intraocular# hemorrhages,# total# retinal# detachment# and# subretinal# hemorrhages#




cloudy#and#total# retinal#detachment#was#suspected.#At# the#age#of# three#years#phthisis#bulbi# in#







We# also# analyzed# three# other# family# members,# the# mother,# the# father# and# an# unaffected#
brother#of#the#index#patient.#The#father#and#the#brother#do#not#have#the#mutation,#whereas#the#
mother# seems# to#be#a#mosaic#of# this# sequence#variation# in# the#NDP# gene.#We#analyzed# saliva#
from# all# four# family# members# as# well# as# blood# from# the#mother.# Currently# we# are# analyzing#














translation# initiation#of# TSPAN12.#The# second#missense#mutation# (p.Leu10Gln)# affects#a#highly#
conserved# amino# acid# and# this# mutation# is# predicted# to# be# deleterious# by# PolyPhen.# The#
missense#mutation#(p.Met35Val)#affects#a#moderately#conserved#amino#acid#and#is#predicted#to#





NDP$ !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70998' c.365A>T' p.Tyr122Phe' Exon'3' probably'damaging'(0.997)' not'tolerated' Class'C15' Misssense'mutation' hemizygous'
71075' c.365A>T' p.Tyr122Phe' Exon'3' probably'damaging'(0.997)' not'tolerated' Class'C15' Misssense'mutation' ev.'mosaic'
' ' ' ' ' ' ' ' '
TSPAN12$ !! !! !! !! !! !! !! !!
Patient! DNA!variant! Protein!variant! Location! PolyPhen!! SIFT! A7GVGD! Effect! Zygosity!
70174' c.1A>G' p.Met1?' Exon'2' 'M' 'M' 'M' Startcodon'affected' heterozygous'
22439' c.29T>A' p.Leu10Gln' Exon'2' probably'damaging'(0.999)' tolerated' Class'C0' Misssense'mutation' heterozygous'
70189' c.67M47A>G'' p.?' Intron'2' 'M' 'M' 'M' Splicing' heterozygous'
22439' c.103A>G' p.Met35Val' Exon'3' benign'(0.000)' tolerated' Class'C0' Misssense'mutation' heterozygous'
70231' c.307A>G' p.Ile103Val' Exon'5' possibly'damaging'(0.565)' not'tolerated' Class'C0' Misssense'mutation' heterozygous'
70138' c.*103'C>A' p.=' 3'UTR' 'M' 'M' 'M' transcript'regulation'' heterozygous'
70138' c.*104'C>A' p.=' 3'UTR' 'M' 'M' 'M' transcript'regulation'' heterozygous'
Table!38:'New'mutations'identified'in'known'disease'causing'genes.
3.3#Recombinant#human#Norrin#–#production,#purification#
Besides& the& screening& of& candidate& genes& involved& in& severe& retinal& dysplasia& in& humans& and& the&
identification&of&disease&causing&sequence&variants,&I&am&particularly&interested&in&the&function&of&Norrin.&
It&seems&that&the&Norrin&protein&is&a&very&important&protein&in&the&early&development&of&the&eye&but&also&
in& brain& development& and&maintenance& of& the& inner& ear.& A& prerequisite& to& investigate& the& function& of&
Norrin& is& the& successful& production& and& purification& of& recombinant& Norrin& protein.& So& far& only& a&
recombinant& Norrin& produced& in& an& E.& coli& system& is& commercially& available& from& R&D& Bioscience.& To&
ensure& proper& posttranslational& modification& and& function& of& the& recombinant& Norrin& we& choose& a&




Human& embryonic& kidney& (HEK293T)& cells& were& stably& transfected& with& wild& type& and& four& different&
diseaseMassociated&mutant& Norrin& expression& constructs.& Several& clones& for& each& Norrin& isoform&were&
isolated&and& further&selected.&Thus&several&mammalian&cell& line&clones&were&established&which&express&
wild&type&rhNorrin&or&mutant&rhNorrin&proteins&respectively.&For&each&isoform&twelve&to&eighteen&clones&




A& cell& pellet& of& each& clone& was& harvested& and& DNA& was& extracted.& Two& pBudCE4.1& internal& primers&











rhNorrin&has&a&predicted& signal&peptide&and& is& supposed& to&be&an&extracellular&protein.& Therefore,& cell&
culture& supernatant& was& analyzed& to& see& whether& rhNorrin& is& secreted& or& not.& Proteins& in& the&
supernatants& of& all& cell& lines&were& separated& by& SDSMPAGE,& blotted& on& a& PVDF&membrane& and& probed&








Different& approaches&were&used& to&produce& rhNorrin& in&high& amounts.&Different& cultivation&devices& as&
well& as&different&media&additives&were&used.&The&best& result& in& respect& to& rhNorrin&amount&and&purity&
was& the& production& of& rhNorrin& using& suspensionMadapted& cells.& The& reduced& amount& of& FCS& in& the&
production& medium& simplifies& purification& of& rhNorrin.& Also& higher& cell& densities& could& be& reached&













rhNorrin& was& purified& from& the& supernatant& of& HEK293T& cells& stably& expressing& wild& type& or& mutant&




























group& filtration& using& two& PDM10& columns& in& serie.& Wild& type& and& mutant& rhNorrin& were& blotted& and&
probed&with&antiMmyc&(Figure&26).&Wild&type&rhNorrin&was&detected&at&the&expected&size&of&around&20kDa,&
















Figure! 27:! Heparin! purification! chromatogram.& TwoMstep& elution& protocol.& The& third& increase& of& elution& buffer&




antibody,& revealed& that& most& of& the& impurities& were& washed& away& from& the& column& in& the& first&














kDa& was& cut& out& of& the& silverMstained& gel& (Figure& 29)& and& submitted& for& mass& spectrometric& analysis&
(Alphalyse,&Denmark).&The&returned&protein&identification&report&confirmed&the&identity&of&rhNorrin&(37%&














To& get& rid& of& these& substances,& different&methods&were& applied,& including& dialysis& and& group& filtration&






















Purified& rhNorrin&was&applied&on&endothelial& cells& to& test&whether& it&has&an&effect&on& the&proliferation&
and&viability&of&endothelial&cells&in#vitro.&Equal&amounts&(20M100ng/µl)&of&wild&type&and&mutant&rhNorrin&


























The& rate& of& migration& was& measured& with& two& different& methods.& Either& by& counting& the& cells& or&
























In& contrast& to& the& other& angiogenesis& assays,& this& is& a& threeMdimensional& assay,& which& is& supposed& to&
mimic&the&in#vivo&situation&better&then&the&twoMdimensional&assays.&In&this&assay&the&endothelial&cells&are&
grown&on&beads&and&endothelial& sprouts& can&grow&away& from&these&beads.&The& length&and&number&of&
sprouts&can&then&be&evaluated.&To&see&the&sprouts&better,&endothelial&cells&were&stained&with&calcein&AM.&




Norrin& has& been& shown& to& be& a& secreted& protein& but& conflicting& results& can& be& found& in& the& literature&




In& our& mammalian& expression& system& rhNorrin& is& secreted& into& the& cell& culture& supernatant,& but& the&
majority&of&rhNorrin&is&bound&to&the&extracellular&matrix.&I&suggested&that&Norrin&might&be&bound&to&HSPG&




is& structurally& similar& to&HSPG&and& can&bind& several& growth& factors& as&well.&We& could& show& that&more&
soluble& rhNorrin& is& present& in& the& supernatant& when& heparin& is& added& to& the& medium& compared& to&
medium&without&heparin&(Figure&36A).&Further&we&could&show&by&western&blot,&when&heparin&is&added&to&





































system& remains& to& be& elucidated.& There& are& two& potential& PM& for& rhNorrin,&OMglycosylation& and& lipide&
modification.&No&NMglycosylation&sites&were&predicted&in&Norrin.&Both&OMglycosylation&and&palmytylation&
of& rhNorrin& have& been& tested& but& since& no& positive& control& was& available& in& both& experiments,& no&
concluding& result& could& be& obtained.& OMglycosylation& of& rhNorrin&was& investigated& using&OMglycosidase&




the& ligandMbased& receptorMcapture& (LRC)& technology,& which& was& developed& by& Andreas& Frei& and&
colleagues& at& the& ETH& Zurich.& I& worked& with& him& on& this& project& during& the& time& the& technology& was&
developed&at& the&ETH,& recently& they&published& the& successful& establishment&of& the&method& (Frei& et& al.&
2012).& Briefly,& they& developed& a& novel& trifunctional& reagent& called& “Triceps”.& One& function& of& this&
molecule&is&that&it&can&be&nonMspecifically&coupled&to&primary&amines&of&lysine&side&chains&in&any&protein&





to& the& ligand& over& the& Triceps& molecule.& After& the& receptorMcapture& reaction,& the& cells& are& lysed& and&
enzymatically&digested&with&trypsin,&and&TricepsMlabeled&peptides&are& isolated&using&streptavidin&beads.&
The& ability& to& be& purified& is& the& third& essential& feature& of& Triceps.& Subsequent& analysis& with& mass&
spectrometry&allows&the&identification&of& ligand&receptor&complexes.&Unfortunately,&a&first&attempt&of&a&
positive& control& experiment& using& rhNorrin& and& FZD4,& LRP5& cotransfected& HEK293T& cells& was& not&









































Two& independent& groups& released& a& first& draft& of& the&human& genome& sequence& in& 2001& (Lander& et& al.&
2001,&Venter&et&al.&2001).&Three&years&later,&a&highMquality&human&genome&assembly&representing&99%&of&
the& human& nucleotide& sequence& was& published& (Collins& et& al.& 2004).& The& human& genome& sequence&
available& in& 2004& was& a& consensus& sequence& from& multiple& individuals.& This& first& human& genome&
sequence&had&a&major&impact&on&the&field&of&human&genetics.&The&rapid&development&of&new,&faster,&and&
cheaper& sequencing& technologies& allowed& the& sequencing&of&more&and&more& individual& genomes,& thus&
increasing& data& of& human& genome& variation& could& be& achieved.& Therefore& these& new& technologies&
contribute& to& a& better& understanding& of& the& variations& between& single& individual& genomes& and& will&
ultimately& lead& us& to& the& new& era& of& personalized& medicine.& The& 1000& Genome& Project& (The& 1000&
Genomes&Project&Consortium&2010),&combines&the&sequence&data&of&2500&individuals&to&detect&sequence&
variants&with&frequencies&as& low&as&1%.&This&ambitious&project& is&the&next&milestone& in&human&genome&
research&and&thus&we&will&better&understand&the&individual&uniqueness&of&our&genome&in&the&future.&&
The& DNA& sequence& of& any& individual& contains& many& sequence& variations,& including& single& nucleotide&
polymorphisms,& which& represent& about& 90%& of& all& human& DNA& polymorphisms,& but& also& small& indels&
(insertions&and&deletions),&and&structural&alterations&like&copy&number&variations&(CNV).&The&combination&
of&these&variations&makes&each&individual&unique&M&this&genetic&variability& is&the&basis&of&the&phenotypic&
differences& between& individuals.& Single& nucleotide& polymorphisms& (SNP,& pronounced& “snip”)& are& DNA&
sequence&variations,&which&occur&when&a&single&nucleotide&(A,&T,&G,&and&C)&is&altered.&SNPs&can&fall&in&the&
coding&or&nonMcoding&region&of&a&gene&or&are&even& located& in& intergenic& regions.&A&sequence&variant& is&
called&polymorphism&as&soon&as&the&frequency&in&the&population&is&1%&or&more.&Sequence&variants&in&the&
coding& region&do&not&have&necessarily& an&effect& on& the&protein& sequence.&Due& to& the&degeneracy,& the&
redundancy& of& the& genetic& code,& different& codons& encode& for& the& same& amino& acid.& These& sequence&
variants& are& called& synonymous& single& nucleotide& polymorphisms& (sSNP).& Synonymous& SNPs& or& silent&
mutations& do& not& have& an& effect& on& the& protein& sequence,& but& they& still&might& have& an& effect& on& the&
function&of&the&gene.&As& it&has&been&described&for&a&synonymous&variant& in& IRGM&with&susceptibility&to&
Crohn's& disease,& which& had& alleleMspecific& consequences& on& protein& expression& (Brest& et& al.& 2011).& A&
nucleotide&exchange&in&the&coding&region&of&a&gene&can&also&lead&to&an&exchange&of&an&amino&acid&and&is&
then& called& nonMsynonymous& single& nucleotide& polymorphism& (nsSNP).& A& nsSNP& that& lead& to& a&
replacement&of&the&naturally&occurring&amino&acid&with&another&amino&acid&and&when&it&is&pathogenic,&it&




when& located& in& the& regulatory& sequences& changes& in& gene& expression& or& RNA& stability& can& be& the&
consequences.& To& interpret& these& individual& sequence& variations& and& to&elucidate&whether& they&play& a&
role& in& the& pathogenesis& is& difficult.& This& actually& might& be& one& of& the& biggest& challenges& of& modern&
molecular&genetics,&to&distinguish&between&neutral&and&disease&causing&sequence&variations.&
A&part&of&this&work&was&to&look&at&DNA&sequence&variants&located&within&the&coding&region&and&50M100&bp&
of& flanking& intronic& region& of& certain& candidate& genes& for& severe& retinal& dysplasia& in& more& then& 200&
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patients.& Several& sequence& alterations& in& different& candidate& genes& have& been& found& during& this&work&
and&functional&effects&thereof&have&been&evaluated&with&different&approaches.&&
4.2#Pathogenicity#prediction#G#a#combinatory#approach#of#multiple#methods##
The& best& way& to& characterize& individual& sequence& variations& involves& a& combinatory& approach& of&
population& genetics,& computational& approaches& and& experimental& assays.& The& first& step& to& identify&
disease& causing& sequence& variations& is& to& look& at& family&members& and& to& see&whether& a&mutation& coM
segregates& with& the& phenotype& in& the& family.& But& often& no& family& members& are& available& for& genetic&
testing& or& only& a& single& family& member& is& affected& by& the& disease& and& no& correlation& can& be& drawn&








sequence&variation.&First,&detected&sequence&variations&were&analyzed& if& they&are& synonymous&or&nonM
synonymous&when& they&were& located& in& the& coding& region.&Missense&mutations&were& further&analyzed&
with& three& different& in# silico& bioinformatic& prediction& algorithms& including& PolyPhenM2& (Adzhubei& et& al.&
2010),&SIFT&(Ng&and&Henikoff&2001),&and&AlignMGVGD&(Mathe&et&al.&2006,&Tavtigian&et&al.&2006)&to&predict&
potential& deleterious& effects& of& these& substitutions& (Table& 36).& The& prediction& results& of& the& three&
different& prediction& programs& have& to& be& seen& with& care.& These& computational& tools& use& certain&
algorithms,& like&evolutionary&conservation&or&biophysical&differences&between&amino&acid& to&assess& the&




approaches& offer& a& cheap& and& straightforward& method& to& predict& the& effect& of& a& missense& mutation.&
Nevertheless,& they& do& not& provide& enough& certainty& to& judge& whether& a& single& missense& mutation& is&





factors&are& the&proneural&genes,&which&are&expressed&prior& to&neuronal&differentiation& in& the&retina.& In&
one&functional& related&group&of& transcription& factors&we&found&several&mutations.&The&most&prominent&
mutation& was& an& inMframe& deletion& of& almost& the& entire& basic& DNA& binding& domain& in& the& atonal#
homologe#7#(ATOH7)&gene.&For&the&discussion&regarding&this&mutation&I&refer&to&the&manuscript.&Beside&
the& deletion& we& found& an& nsSNP& three& times& in& our& cohort,& which& might& be& a& risk& allele& for& retinal&
dysplasia.&In&addition,&we&found&a&mutation&in&the&3’UTR&that&might&affect&ATOH7&RNA&level.&Since&we&do&
not& have& access& to& a& patient& cellMline,& we& could& not& further& investigate& the& effect& of& this& mutation&
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experimentally.&In&a&second&proneural&gene&(NEUROD1)&an&inMframe&deletion&of&a&single&amino&acid&was&




to&his&DNA.&NEUROD1& is& implicated& in&early&eye,&ear&and&brain&development&and& therefore&might&be&a&
modifier& gene& for&Norrie&disease& (Jahan&et&al.& 2010,& Liu&et& al.& 2000).&ATOH7&and&NEUROD1&bind&TCF3,&
another& transcription& factor& which& is& also& involved& in& Wnt& signaling& in& the& retina& (Wu& et& al.& 2012).&
Therefore,& we& established& PCR& to& analyze& the& coding& region& of& bHLH& domain& of& TCF3& –& so& far& the&
screening& for& this& gene& is& outstanding.& Other& genes,& which& might& be& of& interest& to& be& screened& for&
mutations,& are& PAX6,& which& is& upstream& of& NEUROD1& and& ATOH7& and& also& important& for& eye&
development.& Other& bHLH& transcription& factors& of& the& atonal& family,& which& are& involved& in& the&
differentiation&of&retinal&neurons&might&be&interesting&to&be&screened&for&mutations.&&
4.4#Adhesion#of#macrophages#and#endothelial#cells#
In& the&nerve& injury& induced&protein&1& (NINJ1,&Ninjurin1)&we& found&one&missense&mutation&near& to& the&
homophilic& adhesion& domain& of& this& protein& and& two& alterations& in& the& 5’UTR& that& might& affect&
transcriptional&regulation.&We&tested&the&mutation&in&a&localization&assay&using&COSM7&cells&and&found&a&
significant&misMlocalization&of&the&mutant&protein.&To&verify&this&observation,&the&localization&experiment&
could& be& repeated& in& a& human& cell& line& like& HEK293T.& In& addition,& since& the& mutation& was& found&
heterozygous,&a&dominantMnegative&effect&of&the&mutant&NINJ1&could&be&considered&due&to&its&homophilic&
interaction,& similar& as& it& has& been& described& for& FZD4& (Kaykas& et& al.& 2004).& To& further& investigate& the&
effect&of&the&mutation&we&have&identified,&I&suggest&to&use&BVM2&cells&in&an&adhesions&assay.&I&organized&
BVM2&cells&from&Prof.&Burkhard&Becher’s&Group&at&the&University&of&Zurich.&So&far&these&cells&could&not&be&




these& cells& are& not& available,& a& luciferase& reporter& assay& could& be& developed& to& see& whether& the&
mutations&have&an&effect&on&the&expression&level&of&the&reporter&construct.&
NINJ1& is& a&promising& candidate&gene& for& retinal& vascular&diseases& since& this&protein&has&been& linked& to&




In& ILK&we& found& four&missense&mutations&and& four& intronic&mutations,&which&might&affect& splicing.&The&
functional&assays&we&performed&to&investigate&ILK&mutations&are&discussed&in&the&following&section.&&
We& performed& immunocytochemical& stainings& to& see&whether& exogenous& ILK& can& be& localized& at& focal&
adhesions.& But& no& clear,& specific,& and& distinct& stainings& for& the& wt& ILK& protein& was& observed& at& focal&
adhesions.& No& differences& between& wt,& p.Arg211Cys,& and& p.Arg317Gln& variants& were& observed& in& the&
immunocytochemical& stainings& (Figure& 16).& This& might& be& due& to& the& fact& that& endogenous& ILK& is&
occupying& all& focal& adhesion& sites& and& the& transiently& expressed& ILK& is& equally& distributed& in& the&
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cytoplasm.&Therefore&this&assay&might&not&be&suitable&to&test&whether&the&mutations&have&an&effect&on&
protein& localization& or& not.& However,& one& ILK& variant& (p.Leu53Met)& could& not& be& detected& by&
immunocytochemistry& in& four& independent& transfections.& Since& this& variant& has& an& alternative& start&
codon,& the&NMterminal& V5& tag& is& not& fused& to& the& protein&when& the& alternative& start& codon& is& used& to&




the& actin& cytoskeleton.& Therefore& the& mutation& might& affect& cytoskeleton& organization! in& addition& to&
catalytic&kinase&activity.&We&coMstained& in& the& immunocytochemical&assay&with&phalloidin,&a&marker& for&
the& cytoskeletal& actin,& and&could&not& see&any&differences&between& this&mutation&and& the&wt& ILK& in& the&
phalloidin&staining.&As&mentioned&before,&the&settings&used&in&the&immunocytochemical&stainings&might&
not& be& suitable& for& functional& characterization& of& mutant& ILK& variants& due& to& endogenous& ILK& that& is&
occupying&the&focal&adheision&sites.&Further,&we&could&not&observe&any&differences&between&p.Arg211Cys&
and&the&wt&ILK,&although&it&has&been&shown&that&a&mutation&at&the&same&position&(p.Arg211Ala)&leads&to&a&
reduction& in& kinase& activity& (Persad& et& al.& 2001).& The& p.Arg211Cys& mutation& was& predicted& to& be&
deleterious&by&all&prediction&programs.&It&affects&the&PHMlike&domain,&which&binds&to&phosphatidylinositolM
3,4,5Mtrisphosphate& (PIP3)& and& is& involved& in& the& PI3KMAkt& signaling& pathway.& Since& ILK& directly& inhibits&
GSK3Mbeta&by&phosphorylation&and&thus&stimulates&nuclear&localization&of&βMcatenin&and&activation&of&the&
βMcateninMLefM1&transcription&factor&(D'Amico&et&al.&2000,&Delcommenne&et&al.&1998,&Tan&et&al.&2001),&we&




cannot& access& the& places& where& it& fulfills& its& function.& We& tried& to& knock& down& endogenous& ILK& with&
siRNA,&to&circumvent&this&problem,&without&any&success&so&far.&
Overall& further& investigations& are& necessary& to& investigate& the& functional& relevance& of& the& identified&




Two& other& genes&were& screened,& which& are& involved& in& the& same&molecular& pathway:& integrin& beta& 3&
(ITGB3)&and&αMparvin&(PARVA).&
In&ITGB3&we&found&one&missense&mutation&(p.Ala283Thr),&which&was&predicted&by&all&three&programs&as&
deleterious,& that& gives& a& high& probability& that& this& mutation& has& a& functional& effect.& Regarding& this&
mutation,&no&functional&experiments&have&been&performed&so&far.&I&suggest&performing&migration&and/or&













activity& of& different& SRF& variants.& Further,& nuclear& localization& assays& using& immunocytochemical&
stainings& or& cell& fractionation& assays& can& be& conducted.& Overall& this& is& an& ongoing& project,& in& which&
especially&Britta&Seebauer& (PhD&student& in&Prof.&Wolfgang&Bergers& Lab)& is& involved& in& collabration&with&




Beside& FEVR,& PFVS,& ROP,& and& Coats’& disease,& the& differential& diagnosis& of& ND& includes& also& bilateral&




stress& that& the& clinical& picture& might& be& similar& or& quite& divergent& M& also& the& genetic& basis& of& these&
diseases&might&share&some&features&but&can&also&be&very&diverse.&The&development&of&the&vertebrate&eye&








play& an& important& role& to& sustain& neuronal& homeostasis& and& ensure& proper& synaptic& function& by&
reabsorbing&neurotransmitters&(Bringmann&et&al.&2009).&In&mouse&(Smith&et&al.&1994)&and&rat&(Downie&et&
al.& 2007)&Müller& cells& upregulate& expression& of& GFAP& in& the& avascular& retina&which& is& an& indicator& for&





of&microglia& could& influence& proper& retinal& development& on& different& levels.& The& invading&microglia&of&
myeloid&origin&could&be&disrupted&which&then&leads&to&an&under&representation&of&microglia&cells&at&the&
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paravascular&space&and&might& lead&to& inappropriate&pruning&and&remodeling&of& the&retinal&vasculature.&
Further,&mutations& in&FZD4&prevent&paracrine&WNT7b&signaling&suggesting&a&mechanism&of&Wnt& ligands&
expressed& by& macrophages,& which& have& an& effect& on& FZD4& present& on& endothelial& cells& (Lobov& et& al.&
2005).& Endothelial& cells& and& myeloid& cells& do& not& express& Norrin& but& when& Norrin& is& present& in& the&
extracellular&space& it&might&have&the&same&effect&as&Wnt7b.& It&was&shown&that&resident&retinal&myeloid&
cells&express&Wnt& ligands&and&regulate&blood&vessel&branching& into&deeper& layers&of& the&retina&by&nonM
canonical&WntMFlt1&pathway&(Stefater&et&al.&2011).&Whether&Norrin&plays&a&role&in&this&mechanism&has&to&








response& during& the& process& of& retinal& development& to& understand& the& underlying& pathophysiological&
mechanisms&of&retinal&dysplasias&including&EVR,&ROP,&DR,&and&other&retinal&diseases.&&
4.9#Recombinant#human#Norrin#(rhNorrin)#
To& obtain& an& unlimited& amount& of& rhNorrin& for& structural& and& functional& studies,& I& have& been& able& to&
successfully&produce&the&rhNorrin&in&a&mammalian&expression&system.&Stable&gene&expression&technology&
has& been& chosen& since& up& to& 20M25& times& higher& productivity& compared& to& transient& gene& expression&
approach&has&been&suggested& (Pham&et&al.&2006,&Wurm&2004).&To&produce& functional& rhNorrin&protein&
we& chose& a&mammalian& system& to& ensure& proper& posttranslational&modification.& Beside& the&wild& type&
rhNorrin&four&diseases&associated&mutant&rhNorrin&isoforms&were&produced&to&ensure&a&proper&negative&





There&are&several& reports& in&the& literature&about&recombinant&human&Norrin.&An&NMterminal&HisMtagged&
rhNorrin&protein&produced&in&the&baculovirus&expression&system&was&not&secreted&in&the&growth&medium&
and& the& majority& of& the& protein& did& not& bind& the& purification& column,& which& probably& was& due& to&






et& al.& 2007).& The& last& report&of& rhNorrin&used&EBNAMHEK293T& cell& but& exchanged& the&natural& occurring&
signal&peptide&by&an&artificial&one&and&could&also&detect&secreted&rhNorrin&in&the&supernatant&(Ohlmann&
et&al.&2010).&All&different&approaches&revealed&different&sizes&of&recombinant&human&Norrin,&which&might&












similar& to& Norrin& (Whitelock& and& Iozzo& 2005).& Heparan& sulfate& proteoglycans& (HSPG)& are& described& as&
extacellular& binding&molecules& for& growth& factor& like&Wnt& proteins,& VEGF,& FGF,& TGFMbeta& (Houck& et& al.&
1992,&Mohammadi&et&al.&2005,&Reichsman&et&al.&1996,&Yayon&et&al.&1991).&PerezMVilar&and&Hill&excluded&
the&binding&of&Norrin& to&HSPG&since& they&could&not&extract&Norrin& from&the&ECM&by&adding&heparin&or&





other& groups& (Ohlmann& et& al.& 2010,& Smallwood& et& al.& 2007),& both& used& Heparin& sepharose& to& purify&







conduct& structural& experiments.& To& enable& a& high& concentration& of& rhNorrin& several& approaches&were&
conducted& including& the&expression&of&Norrin& in&different& systems.&Namely,& in& Pichia&pastoris& together&
with&the&Paul&Scherrer&Institute&(PSI)&and&in&a&transient&transfection&approach&together&with&the&EPFL&in&





production.&To&eliminate&unwanted& impurities& it& is& important& to& reduce&as&many& impurities&as&possible&
from&the&beginning.&HEK293T&cells&can&be&adapted&to&grow&in&medium&with&less&or&for&a&certain&time&even&




would&be& important& to&agitate& the& flasks&during& the&cultivation.&A&good&starting&material& simplifies& the&
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subsequent& purification,& more& rhNorrin& is& available& in& less& volume& and& fewer& impurities& have& to& be&
removed.&&
The&purification&of&rhNorrin&can&be&accomplished&with&different&methods.&In&our&approach&we&have&a&HisM
tag,&which& can& be& used& to& purify& rhNorrin&with& IMAC.& Alternatively,& the& heparin& binding& properties& of&
Norrin&can&be&used&to&purify&untagged&rhNorrin.&Heparin&purification&should&be&preferred&since&less&harsh&
elution&conditions&can&be&chosen.&Heparin&buffers&might&be&better&tolerated& in&the&functional&assays& in#







we& could& not& obtain& any& clear& results& regarding& an& effect& of& wild& type& rhNorrin& compared& to&mutant&
rhNorrin&isoforms&in&these&functional&assays.&On&the&other&hand,&others&could&show&an&effect&of&rhNorrin&
on&microvascular&endothelial&cells&regarding&proliferation,&migration&and&tube&formation&(Ohlmann&et&al.&




The& expression& of& Norrin& in& astrocytes& of& the& CNS& and& the& subventricular& zone& (SVZ),& which& is& a&
neurogenic&region,&indicates&its&involvment&in&embryonic&neural&stem&cell&differentiation&(Doetsch&1999).&
Also&other&growth&factors&can&act&in&a&dual&form&in&neuroM&and&angiogenesis,&like&recently&shown&VEGF3&
(Calvo& 2011).& The& inhibition& of& TGFMβ& family& signaling& directs& commitment& of& embryonic& stem& cells& to&
neuroectoderm& lineages,& resulting& in& the& formation& of& embryonic& neural& stem& cells.& Embryonic& neural&
stem&cells&differentiate& into&neurons&and&glia& (astrocytes&and&oligodendrocytes)&of& the&central&nervous&
system.&Norrin&seems&to&play&an&important&role&in&early&neurectoderm&induction&(Xu&et&al.&2012).&Norrin&
might&have& similar& functions& like& chordin&during&neural& induction&and&gastrulation.&These& two&proteins&
might& even& have& redundant& activities.& During& neuronal& tissue& formation&Wnt& signaling& pathways& play&
different& roles.& At& early& blastula& stages,& canonical&Wnt& signaling& is& important& for& the& formation& of& the&
dorsalMventral&axis&formation&via&activation&of&Tcf3&(Schneider&et&al.&1996,&Harland&2000,&Heasman&2006).&
Later&during&neurula&stage,& it& regulates&neuronal&differentiation&via& inhibition&of&NeuroD&(Marcus&et&al.&
1998).&Further,&the&inhibition&of&Wnt&signaling&promotes&neural&differentiation&in&Xenopus,&chicken&and&
mouse& ES& cell& (Glinka& et& al.& 1998,&Wilson& and&Edlund&2001,&Aubert& et& al.& 2002).& Thus&Norrin&might&be&





































elucidation& of& the& molecular& mechanisms& of& retinal& diseases.& Three& very& interesting& projects& were&
initiated&by&these&excellent&scientists.&
&
Prof.& Kurt& Ballmer,& Dr.& Rolf& Jaussi,& and& Dr.& David& Hacker& for& the& collaboration& which& helped& me& to&
succesfully&produce&rhNorrin.&I&learned&a&lot&from&these&experienced&scientists.&
&
Last& but& not& least,& I& would& like& to& thank& my& family& and& friends!& My& beloved& wife,& Vanessa,& for& your&
persistent& encouragement,& sympathy,& love,& and& for& always& believing& in& me.& My& little& son,& Lias,& for&
existing.& You& are& truly& the&most& wonderful& creature& all& over& the&world.&My& parents,&Wilma& and& Hans&
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Insert* Backbone* Description* Tag* Origin*
non& pENTR™/D/TOPO®&& Gateway&Entry& non& Life&Technologies,&Zug,&Switzerland&
non& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Life&Technologies,&Zug,&Switzerland&
non& pcDNA3.1/V5/His&& Mammalian&Expression& V5,&6xHis(C/term)& Life&Technologies,&Zug,&Switzerland&
non& pcDNA3.2/V5/DEST& Mammalian&Expression& V5&(C/term)& Life&Technologies,&Zug,&Switzerland&
non& pBudCE4.1& Mammalian&Expression& V5&(N/term),&6xHis&(C/term)& Life&Technologies,&Zug,&Switzerland&
EGFP& pEGFP/C1& transfection&control& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&J.&Neidhardt&group&
hAtoh7&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hAtoh7&del& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&del& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hATOH7&p.Arg65Gly&& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hAtoh7&wt& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hAtoh7&del& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&wt& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&del& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hATOH7&p.Arg65Gly&& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hAtoh7&wt& pcDNA3.1/V5/His&& Mammalian&Expression& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hAtoh7&del& pcDNA3.1/V5/His&& Mammalian&Expression& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&wt& pcDNA3.1/V5/His&& Mammalian&Expression& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
NLS_hAtoh7&del& pcDNA3.1/V5/His& Mammalian&Expression& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hATOH7&p.Arg65Gly&& pcDNA3.1/V5/His&& Mammalian&Expression& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hILK&wt& pDONR223& Template&for&cloning& non& Addgene,&Cambridge,&MA,&USA&
hILK&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&p.Leu53Met& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&p.Arg211Cys& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&p.Arg317Gln& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&wt& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&wt& pcDNA3.2/DEST& Mammalian&Expression& V5&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&S.&Dold&
hILK&p.Leu53Met& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&p.Leu53Met& pcDNA3.2/DEST& Mammalian&Expression& V5&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&S.&Dold&
hILK&p.Arg211Cys& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hILK&p.Arg317Gln& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
 180 
mILK&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Leu53Met& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Arg211Cys& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Arg317Gln& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&wt& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Leu53Met& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Arg211Cys& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
mILK&p.Arg317Gln& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&
hITGB3&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hITGB3&p.Ala283Thr& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Mohn&&&L.&Sollfrank&
hNDP&wt& pBudCE4.1& Mammalian&Expression& myc,&6xHis&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&U.&Luhmann&
hNDP&p.Cys95Arg& pBudCE4.1& Mammalian&Expression& myc,&6xHis&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&U.&Luhmann&
hNDP&p.Cys96Trp& pBudCE4.1& Mammalian&Expression& myc,&6xHis&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&U.&Luhmann&
hNDP&p.Arg121Leu& pBudCE4.1& Mammalian&Expression& myc,&6xHis&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&U.&Luhmann&
hNDP&p.Arg121Trp& pBudCE4.1& Mammalian&Expression& myc,&6xHis&(C/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&U.&Luhmann&
hNINJ1& pCMV6/XL5& Template&for&cloning& non& OriGene&Technologies,&Rockville,&USA&
hNINJ1&wt& pENTR™/D/TOPO®&& Gateway&Entry& non& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Sollfrank&
hNINJ1&p.Ala42Thr& pcDNA3.1/nV5/DEST& Mammalian&Expression& V5&(N/term)& Institute&of&Medical&Molecular&Genetics,&Zürich,&L.&Sollfrank&
pTopflash&& pTA/Luc&backbone& TCF/LEF&luciferase&reporter& non& Institute&of&Molecular&Life&Sciences,&Zürich,&K.&Basler&group&
pFopflash& pTA/Luc&backbone& no&TCF/LEF&reporter&& non& Institute&of&Molecular&Life&Sciences,&Zürich,&K.&Basler&group&
pRL& pRL/CMV& normalization& non& Promega,&Madison,&USA&
pE7/βA& pPGV& (CANNAG)&reporter& non& Institute&of&Virus&Research,&Kyoto&University,&Ryoichiro&Kageyama&





























gene( gene(selection( primer(design( genetic(screening( sequence(data(analysis( construct(cloning( functional(assays(
ATOH7& LM& LM,&SF& SF& LM,&SF& LM& LM,&BS&
NEUROD1& LM& LM,&SF& SF& LM,&SF& +& +&
NINJ1& LS,&LM,&WB& LM,&LS& LM,&LS& LS& LM,&LS& LM,&LS&
ZNF408& FC,&RC& LM,&LS& LM,&LS& LM,&LS& RC& RC&
ILK& HY,&RA& LM& SF,&MW,&LM,&LS& LM,&LS& LM,&LS& HY,&LM,&LS&
ITGB3& HY,&RA,&LM,&LS,&WB& LM,&LS& SF,&MW,&LM,&LS& LM,&LS& LM,&LS& +&
PARVA& HY,&RA,&LM,&LS,&WB& LM,&LS& LM,&LS& LM,&LS& +& +&
SRF& AN& SF& SF& LM,&LS,&MF,&SF,WB,&JZ& BS& LM,&BS,&JZ&
MKL1& AN,&LM,&WB,&JZ& SF& SF,&WM&& LM,&SF,&MW& BS& LM,&BS,&JZ&
MKL2& AN,&LM,&WB,&JZ& SF& SF& LM,&SF,&BS& BS& LM,&BS,&JZ&
NDP& WB& WB& SF& SF,&LM& +& +&
TSPAN12& LM,&NS,&WB,&JZ& NS& SF& LM,&NS,&SF& +& +&
       
  Abbrivation( First(name( Last(name(   
  AN& Alfred&& Nordheim&   
  BS& Britta& Seebauer&   
  FC& Frans&& Cremers&   
  HY& Hiroyuki& Yamamoto&   
  JZ& Jurian& Zürcher&   
  LM& Lucas& Mohn&   
  LS& Lea&& Sollfrank&   
  MF& Martin& Fritsche&   
  MW& Mariana& Wittmer&   
  NS& Nikolaus& Schäfer&   
  RA& Ralf&& Adams&   
  RC& Rob& Collin&   
  SF& Silke& Feil&   
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